Purple excitable tandem dyes and methods of making and using same
By designing a purple excitable tandem fluorescent dye, the problem of low excitation efficiency of existing fluorescent dyes under purple lasers was solved, improving the signal-to-noise ratio and emission brightness, and enhancing the detection capability of biological samples.
Patent Information
- Application Number
- CN202380028524.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-21
- Filing Date
- 2023-03-13
- Publication Date
- 2024-11-12
AI Technical Summary
Existing fluorescent dyes are difficult to excite with violet wavelengths in biological applications, which limits their efficiency and signal-to-noise ratio when used with common violet lasers.
A purple-excited tandem fluorescent dye was developed, comprising a non-conjugated polymer backbone, a purple-excited donor fluorophore, and an acceptor fluorophore. Based on energy transfer relationships, a purple-excited tandem dye, its preparation method, and a kit were provided.
Effective excitation by a violet laser was achieved, improving the signal-to-noise ratio and emission brightness, and enhancing the signal detection capability in biological samples.
Smart Images

Figure CN118946640A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] Pursuant to 35 U.S.C. §119(e), this application claims priority to the filing date of U.S. Provisional Patent Application Serial No. 63 / 322,120, filed on March 21, 2022, the disclosure of which is incorporated herein by reference in its entirety. Background Art
[0003] Fluorescent dye is such a compound, when the light of the wavelength absorbed by it is irradiated, it (usually) emits light of different wavelengths. Fluorescent dye has multiple applications in biochemistry, biology and medicine, for example, for diagnostic kits, microscopy or drug screening. Fluorescent dye is characterized by many parameters, allowing the user to select suitable dye according to the desired purpose. The parameters of interest include excitation wavelength maximum, emission wavelength maximum, Stokes shift, extinction coefficient, fluorescence quantum yield and fluorescence lifetime. Dye can be selected according to the application of interest, so as to allow the excitation radiation to penetrate into the biological sample, thereby minimizing background fluorescence and / or realizing high signal to noise ratio.
[0004] Molecular recognition involves the specific binding of two molecules. Molecules with binding specificity for a target biomolecule can be used in a variety of research and diagnostic applications, such as labeling and separation of analytes, flow cytometry, in situ hybridization, enzyme-linked immunosorbent assay (ELISA), Western blot analysis, magnetic cell separation, and chromatography. Target biomolecules can be detected by labeling with fluorescent dyes.
[0005] Some applications (e.g., flow cytometry applications) employ combinations or panels of different fluorescently labeled specific binding members (e.g., antibodies) to detect multiple different targets, such as internal or cell surface markers. In such applications, a variety of different fluorescent dyes are used for the same sample, wherein the multiple different fluorescent dyes are distinguishable from each other in terms of excitation and / or emission maxima. One class of fluorescent dyes useful in such applications is tandem fluorescent dyes. Tandem fluorescent dyes are compounds having two covalently linked different fluorophores, which can be covalently linked to each other directly or through a linking group. One of the fluorophores is used as a donor fluorophore and the other fluorophore is used as an acceptor fluorophore. The donor and acceptor fluorophores together form a fluorescence resonance energy transfer (FRET) pair. Such FRET pairs are characterized by a unique dye having the excitation characteristics of a donor fluorophore and the emission characteristics of an acceptor fluorophore. Summary of the invention
[0006] The inventors have recognized a need for tandem fluorescent dyes in which the donor fluorophore is excited in the violet wavelength range, for example, so as to be excitable by commonly used violet lasers. Embodiments of the present invention meet this need.
[0007] A violet excitable tandem dye is provided. The tandem dye of an embodiment of the present invention comprises: a non-conjugated polymer backbone; one or more violet excitable donor fluorophores connected to the non-conjugated polymer backbone; and one or more acceptor fluorophores connected to the non-conjugated polymer backbone; wherein the donor and acceptor fluorophores are in an energy transfer relationship. Also provided are methods for preparing and using the tandem dye, and a kit, the kit comprising the dye and being useful in embodiments of the method. BRIEF DESCRIPTION OF THE DRAWINGS
[0008] The present invention can be better understood by reading the following detailed description in conjunction with the accompanying drawings, which include the following figures:
[0009] Figure 1 Donor absorption and emission spectra are provided for three coumarin violet excitable donor fluorophores useful in tandem dyes according to embodiments of the present invention.
[0010] Figure 2 Absorption and emission spectra of seven different violet excitable tandem dyes according to embodiments of the present invention are provided. DETAILED DESCRIPTION
[0011] definition
[0012] As used herein, the terms "chemoselective functional group" and "chemoselective tag" are used interchangeably and refer to a functional group that, in certain cases, can selectively react with another compatible functional group to form a covalent bond after optionally activating one of the functional groups. Chemoselective functional groups of interest include, but are not limited to, thiols and maleimides or iodoacetamides, amines and carboxylic acids or their active esters, and groups that can react with each other via click chemistry, such as azides and alkynyl groups (e.g., cyclooctynyl), tetrazines, trans-cyclooctenes, dienes and dienophiles, as well as azides, sulfur (VI) fluoride exchange chemistry (SuFEX), sulfonyl fluorides, and hydroxyls, hydrazides, hydrazines, aldehydes, ketones, azidos, alkynes, phosphines, epoxides, and the like.
[0013] As used herein, the term "sample" refers to a material or mixture of materials containing one or more analytes of interest, in some cases in liquid form. In some embodiments, the term, when used in its broadest sense, refers to any plant, animal, or bacterial material containing cells or producing cell metabolites, such as tissues or liquids separated from individuals (including but not limited to plasma, serum, cerebrospinal fluid, lymph, tears, saliva, and tissue sections) or tissues or liquids separated from in vitro cell culture components, as well as samples from the environment. The term "sample" may also refer to a "biological sample". As used herein, the term "biological sample" refers to a whole organism or a subset of its tissues, cells, or components (e.g., body fluids, including but not limited to blood, mucus, lymph, synovial fluid, cerebrospinal fluid, saliva, amniotic fluid, amniotic blood, urine, vaginal fluid, and semen). "Biological sample" can also refer to a homogenate, lysate or extract prepared from a whole organism or a subset of its tissues, cells or components or its fractions or parts, including but not limited to plasma, serum, spinal fluid, lymph fluid, external parts of the skin, respiratory tract, intestinal and urogenital tracts, tears, saliva, milk, blood cells, tumors and organs. In certain embodiments, the sample has been taken out from an animal or plant. The biological sample may include cells. The term "cell" is used in its conventional sense to refer to the basic structural unit of a living organism (both eukaryotic and prokaryotic organisms), having at least a nucleus and a cell membrane. In certain embodiments, cells include prokaryotic cells, such as prokaryotic cells from bacteria. In other embodiments, cells include eukaryotic cells, such as cells obtained from biological samples from animals, plants or fungi.
[0014] The terms "support binding" and "connected to a support" are used interchangeably and refer to a portion (e.g., a specific binding member) that is covalently or non-covalently connected to a support of interest. Covalent bonding can involve a chemical reaction of two compatible functional groups (e.g., two chemoselective functional groups, an electrophilic group, and a nucleophilic group, etc.) to form a covalent bond between two portions of interest (e.g., a support and a specific binding member). In some cases, non-covalent bonding can involve specific binding between two portions of interest (e.g., two affinity moieties, such as a hapten and an antibody or a biotin moiety and streptavidin, etc.). In some cases, non-covalent bonding can involve the absorption of a substrate.
[0015] The term "polypeptide" refers to a polymeric form of amino acids of any length, including peptides with a length range of 2-50 amino acids and polypeptides with a length greater than 50 amino acids. The terms "polypeptide" and "protein" are used interchangeably herein. The term "polypeptide" includes polymers of coded amino acids and non-coded amino acids, polymers of chemically or biochemically modified or derived amino acids, and polypeptides with modified peptide backbones, wherein conventional backbones have been replaced by non-naturally occurring or synthetic backbones. Polypeptides can have any convenient length, for example, 2 or more amino acids, such as 4 or more amino acids, 10 or more amino acids, 20 or more amino acids, 50 or more amino acids, 100 or more amino acids, 300 or more amino acids, such as up to 500 or 1000 or more amino acids." Peptide" can be 2 or more amino acids, such as 4 or more amino acids, 10 or more amino acids, 20 or more amino acids, such as up to 50 amino acids. In some embodiments, the length of the peptide is 5 to 30 amino acids.
[0016] As used herein, the term "isolated" refers to a fraction of interest that is at least 60% free, at least 75% free, at least 90% free, at least 95% free, at least 98% free, or even at least 99% free from other components with which the fraction of interest was associated prior to purification.
[0017] A "plurality" contains at least 2 members. In some cases, a plurality can have 5 or more, e.g., 6 or more, 7 or more, 8 or more, 9 or more, 10 or more, 20 or more, 30 or more, 40 or more, 50 or more, 60 or more, 70 or more, 80 or more, 90 or more, 100 or more, 300 or more, 1000 or more, 3000 or more, 10,000 or more, 100,000 or more members.
[0018] Numeric ranges are inclusive of the numbers defining the range.
[0019] The term "specific binding" refers to a direct association between two molecules, for example due to covalent, electrostatic, hydrophobic and ionic and / or hydrogen bonding interactions, including interactions such as salt bridges and water bridges. Specific binding members describe members of a pair of molecules that have binding specificity to each other. The members of a specific binding pair may be naturally derived or wholly or partially synthetically produced. One member of the molecular pair has an area on its surface or cavity that specifically binds to and is therefore complementary to the specific spatial and polar organization of the other member of the molecular pair. The members of the pair therefore have the property of specifically binding to each other. Examples of specific binding member pairs are antigen-antibody, biotin-avidin, hormone-hormone receptor, receptor-ligand, enzyme-substrate. Specific binding members of a binding pair exhibit high affinity and binding specificity for binding to each other. Typically, the affinity between a pair of specific binding members is measured by K. d (dissociation constant), which is 10 -6 M or lower, e.g. 10 - 7 M or lower, including 10 -8 M or lower, e.g. 10 -9 M or lower, 10 -10 M or lower, 10 -11 M or lower, 10 -12 M or lower, 10 -13 M or lower, 10 -14 M or lower, including 10 -15 M or lower. "Affinity" refers to the strength of binding, and increased binding affinity is associated with a lower KD. In embodiments, affinity is determined by surface plasmon resonance (SPR), for example, as used by a Biacore system. The affinity of a molecule to another molecule is determined by, for example, measuring the binding kinetics of the interaction at 25°C. "Affinity" refers to the strength of binding, and increased binding affinity is associated with a lower KD. In embodiments, affinity is determined by surface plasmon resonance (SPR), for example, as used by a Biacore system. The affinity of a molecule to another molecule is determined by, for example, measuring the binding kinetics of the interaction at 25°C.
[0020] Specific binding members can be proteinaceous. As used herein, the term "proteinaceous" refers to a portion consisting of amino acid residues. The proteinaceous portion can be a polypeptide. In some cases, proteinaceous specific binding members are antibodies. In certain embodiments, proteinaceous specific binding members are antibody fragments, such as antibody binding fragments that specifically bind to polymer dyes. As used herein, the terms "antibody" and "antibody molecule" are used interchangeably and refer to a protein consisting of one or more polypeptides that are substantially encoded by all or part of recognized immunoglobulin genes. Recognized immunoglobulin genes (such as those in humans) include κ (k), λ (l) and heavy chain loci, which together constitute countless variable region genes, and constant region genes μ (u), δ (d), γ (g), σ (e) and α (a), which encode IgM, IgD, IgG, IgE and IgA isotypes, respectively. The immunoglobulin light chain or heavy chain variable region is composed of a "framework" region (FR) interrupted by three hypervariable regions (also referred to as "complementarity determining regions" or "CDRs"). The scope of the framework region and CDR has been precisely defined (see "Sequences of Proteins of Immunological Interest," E. Kabat et al., USDepartment of Health and Human Services, (1991)). The numbering of all antibody amino acid sequences discussed herein conforms to the Kabat system. The sequences of the framework regions of different light chains or heavy chains are relatively conserved within a species. The framework region of an antibody, that is, the combined framework region of the light chain and the heavy chain, is used to position and adjust the CDR. The CDR is primarily responsible for binding to the antigen epitope. The term "antibody" is intended to include full-length antibodies and may refer to natural antibodies, engineered antibodies, or recombinantly produced antibodies from any organism for experimental, therapeutic or other purposes, as further defined below.
[0021] Antibody fragments of interest include, but are not limited to, Fab, Fab', F(ab')2, Fv, scFv or other antigen-binding subsequences of antibodies, which are either produced by modifying the entire antibody or synthesized de novo using recombinant DNA technology. Antibodies can be monoclonal or polyclonal and can have other specific activities on cells (e.g., antagonistic antibodies, agonistic antibodies, neutralizing antibodies, inhibitory antibodies or stimulating antibodies). It is understood that antibodies can have additional conservative amino acid substitutions that have substantially no effect on antigen binding or other antibody functions.
[0022] In certain embodiments, the specific binding member is a Fab fragment, a F(ab')2 fragment, a scFv, a diabody or a triabody. In certain embodiments, the specific binding member is an antibody. In some cases, the specific binding member is a murine antibody or a binding fragment thereof. In some cases, the specific binding member is a recombinant antibody or a binding fragment thereof.
[0023] Method described herein may include a plurality of steps. As required, each step may be performed after a predetermined amount of time between steps. Therefore, the time between performing each step may be 1 second or longer, 10 seconds or longer, 30 seconds or longer, 60 seconds or longer, 5 minutes or longer, 10 minutes or longer, 60 minutes or longer and include 5 hours or longer. In certain embodiments, each subsequent step is performed immediately after the previous step is completed. In other embodiments, step may be performed after the incubation or waiting time after completing the previous step, and this incubation or waiting time are for example the waiting time of several minutes to overnight.
[0024] As used herein, the terms "assess," "determine," "measure," "evaluate," and "measure" are used interchangeably and include both quantitative and qualitative determinations.
[0025] As used herein, the term "separation" refers to the physical separation of two elements (eg, by size or affinity, etc.) as well as the degradation of one element while leaving the other element intact.
[0026] The term "joint" or "connector" refers to a connecting portion that connects two groups and has a length of 100 atoms or less of a skeleton. A joint or a connector can be a covalent bond connecting two groups or a chain of 1 to 100 atoms in length, such as a chain of 1, 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 18, 20 or more carbon atoms in length, wherein the joint can be a straight chain, a branched chain, a cyclic or a single atom. In some cases, the joint is a branched joint, and a branched joint refers to a connecting portion that connects three or more groups. In some cases, one, two, three, four or five or more carbon atoms of the joint skeleton can be optionally substituted by sulfur, nitrogen or oxygen heteroatoms. In some cases, the joint skeleton includes a connecting functional group, such as ether, thioether, amino, amide, sulfonamide, carbamate, thiocarbamate, urea, thiourea, ester, thioester or imines. The key between the skeleton atoms can be saturated or unsaturated, and in some cases, there is no more than one, two or three unsaturated bonds in the joint skeleton. The joint may include one or more substituents, such as alkyl, aryl or alkenyl groups. The joint may include, but is not limited to, polyethylene glycol; ethers, thioethers, tertiary amines, alkyls, which may be linear or branched, such as methyl, ethyl, n-propyl, 1-methylethyl (isopropyl), n-butyl, n-pentyl, 1,1-dimethylethyl (tert-butyl), etc. The joint skeleton may include a cyclic group, such as an aryl, heterocyclic or cycloalkyl group, wherein 2 or more atoms of the cyclic group, such as 2, 3 or 4 atoms, are included in the skeleton. The joint may be cleavable or non-cleavable.
[0027] As used herein, the terms "water-soluble group," "water-soluble group," and WSG are used interchangeably and refer to a group or substituent that is well solvated in an aqueous environment, e.g., under physiological conditions, and confers improved water solubility to the molecule to which it is attached. WSG can increase the solubility of a tandem dye or a component thereof (e.g., a donor or acceptor fluorophore) in a predominantly aqueous solution compared to a control tandem dye or a component thereof lacking WSG. The water-soluble group can be any convenient hydrophilic group that is well solvated in an aqueous environment.
[0028] Various water-soluble polymer groups can be applicable to the WSG of the theme dye.Any convenient water-soluble group (WSG) can be included in the dye described herein to provide higher water solubility.Although the increase in solubility may be different, in some cases, the increase (compared with the compound without WSG) is 2 times or more, such as 5 times, 10 times, 25 times, 50 times, 100 times or more.In some cases, the hydrophilic water-soluble group is charged, such as positively charged or negatively charged.In some cases, the hydrophilic water-soluble group is a neutral hydrophilic group.In some embodiments, WSG is side chain (for example, as described herein).In some cases, WSG is linear.In some embodiments, WSG is a hydrophilic polymer, for example, polyethylene glycol, modified PEG, peptide sequence, peptoid, carbohydrate, oxazoline, polyol, dendritic polymer, dendritic polyglycerol, cellulose, chitosan or its derivatives. Water-soluble groups of interest include, but are not limited to, carboxylates, phosphonates, phosphates, sulfonates, sulfates, sulfinates, sulfoniums, esters, polyethylene glycol (PEG) and modified PEGs, hydroxyls, amines, amino acids, ammonium, guanidinium, pyridinium, polyamines and sulfoniums, polyols, linear or cyclic sugars, primary, secondary, tertiary or quaternary amines and polyamines, phosphonate groups, phosphite groups, ascorbate groups, glycols including polyethers, -COOM', -SO3M', -PO3M', -NR3 + 、Y′、(CH2CH2O) p R and mixtures thereof, wherein Y' can be any halogen, sulfate, sulfonate or oxyanion, p can be from 1 to 500, each R can independently be H or an alkyl group (e.g., methyl) and M' can be a cationic counterion or hydrogen, --(CH2CH2O) yy CH2CH2XR yy 、--(CH2CH2O) yy CH2CH2X--、--X(CH2CH2O) yy CH2CH2--, ethylene glycol and polyethylene glycol, wherein yy is selected from 1 to 1000, and X is selected from O, S and NR ZZ , and R ZZ and R YY Independently selected from H and C 1-3 In some cases, WSG is (CH2) x (OCH2CH2) y OCH3, wherein each x is independently an integer from 0 to 20, and each y is independently an integer from 0 to 50. In some cases, the water-soluble group includes a nonionic polymer (eg, a PEG polymer) substituted at the terminal end with an ionic group (eg, a sulfonate group).
[0029] In some embodiments of the formula, pendant groups of interest include those selected from the group consisting of (CH2) x (OCH2CH2) y OCH3 and benzyl substituents, in (CH2) x (OCH2CH2) y In OCH3, each x is independently an integer from 0 to 20, each y is independently an integer from 0 to 50; and the benzyl group is optionally substituted by one or more halogen, hydroxyl, C1-C 12 Alkoxy or (OCH2CH2) z OCH3 substitution, wherein each z is independently an integer from 0 to 50. In some cases, the substituent is (CH2)3(OCH2CH2) 11 In some embodiments, one or more substituents are benzyl substituted with at least one WSG group (e.g., one or two WSG groups) selected from (CH2) x (OCH2CH2) y OCH3, wherein each x is independently an integer from 0 to 20, and each y is independently an integer from 0 to 50.
[0030] Multiple WSG can be included in the single position of the theme dye by a branched joint. In certain embodiments, the branched joint is an aralkyl substituent further substituted by a water-soluble group. Therefore, in some cases, the branched joint group is a substituent of a dye, which connects the dye to two or more water-soluble groups. In certain embodiments, the branched joint is an amino acid, for example, a lysine amino acid connected to three groups by an amino group and a carboxylic acid group. In some cases, multiple WSGs are added by a branched joint to give the dye ideal solubility. In some cases, WSG is a water-soluble nonionic side chain group that can give more than 50mg / mL. In some cases, WSG is a water-soluble nonionic side chain group that can give more than 100mg / mL. In some embodiments, the dye includes a substituent selected from an alkyl, an aralkyl and a heterocyclic group, and each group is further replaced by a hydrophilic polymer group including a water-soluble group, such as polyethylene glycol (PEG) (for example, a PEG group of 6-24 units).
[0031] Interesting water-soluble polymers that can be used in WSG include polyethylene glycol (PEG) groups or modified PEG groups. Interesting water-soluble polymers include, but are not limited to, polyalkylene oxide-based polymers, such as polyethylene glycol "PEG" (see, for example, "Poly (ethylene glycol) Chemistry: Biotechnical and Biomedical Applications", JM Harris, Ed., Plenum Press, New York, NY (1992); and "Poly (ethylene glycol) Chemistry and Biological Applications", JM Harris and S. Zalipsky, Eds., ACS (1997); and International Patent Applications: WO 90 / 13540, WO 92 / 00748, WO 92 / 16555, WO 94 / 04193, WO94 / 14758, WO 94 / 17039, WO 94 / 18247, WO 94 / 28937, WO 95 / 11924, WO 96 / 00080, WO 96 / 23794, WO 98 / 07713, WO 98 / 41562, WO 98 / 48837, WO 99 / 30727, WO 99 / 32134, WO 99 / 33483, WO 99 / 53951, WO 01 / 26692, WO 95 / 13312, WO 96 / 21469, WO 97 / 03106, WO 99 / 45964 and U.S. Patent Nos. 4,179,337; 5,075,046; 5,089,261; 5,100,992; 5,134,192; 5,166,309; 5,171,264; 5,213,891; 5,219,564; 5,275,838; 5,281,698; 5,298,643; 5,312,808; 5,321,095; 5,324,844; 5,349,001; 5,352,756; 5,405,877; 5,455,027; 5,446,090; 5,470,829; 5,478,805; 5,567,422; 5,605,976; 5,612,460; 5,614,549; 5,618,528; 5,672,662; 5,637,749; 5,643,575; 5,650,388; 5,681,567; 5,686,110; 5,730,990; 5,739,208; 5,756,593; 5,808,096; 5,824,778; 5,824,784; 5,840,900; 5,874,500; 5,880,131; 5,900,461; 5,902,588; 5,919,442; 5,919,455; 5,932,462; 5,965,119; 5,965,566; 5,985,263; 5,990,237; 6,011,042; 6,013,283; 6,077,939; 6,113,906; 6,127,355; 6,177,087; 6,180,095; 6,194,580; 6,214,966).
[0032] Examples of water-soluble polymers of interest include, but are not limited to, those containing polyalkylene oxides, polyamide alkylene oxides, or derivatives thereof, including polyalkylene oxides and polyamide alkylene oxides containing ethylene oxide repeating units of the formula -(CH2-CH2-O)-. Other examples of polymers of interest include those having the formula -[C(O)-XC(O)-NH-Y-NH]n- or -[NH-Y-NH-C(O)-XC(O)] n -a polyamide having a molecular weight greater than 1,000 Daltons, wherein X and Y are divalent groups which may be the same or different and which may be branched or linear, and n is a non-contiguous integer from 2 to 100, such as from 2 to 50, and wherein one or both of X and Y comprise a biocompatible, substantially non-antigenic, water-soluble repeating unit which may be linear or branched. Other examples of water-soluble repeating units include ethylene oxide of the formula -(CH2-CH2-O)- or -(O-CH2-CH2)-. The number of such water-soluble repeating units may vary significantly, with the number of such units being from 2 to 500, 2 to 400, 2 to 300, 2 to 200, 2 to 100, 6-100, such as from 2 to 50 or 6 to 50. An example of an embodiment is one in which one or both of X and Y are selected from: -((CH2) n1 -(CH2-CH2-O) n2 -(CH2)- or -((CH2) n1 -(O-CH2-CH2) n2 -(CH2) n-1 -), wherein n1 is 1 to 6, 1 to 5, 1 to 4 or 1 to 3, and wherein n2 is 2 to 50, 2 to 25, 2 to 15, 2 to 10, 2 to 8 or 2 to 5. Further examples of embodiments are those wherein X is -(CH2-CH2)-, and wherein Y is -(CH2-(CH2-CH2-O)3-CH2-CH2-CH2)- or -(CH2-CH2-CH2-(O-CH2-CH2)3-CH2)-.
[0033] The term "modified polymer", such as modified PEG, refers to a water-soluble polymer that is modified or derivatized at either or both ends to, for example, include a terminal substituent (e.g., a terminal alkyl, substituted alkyl, alkoxy or substituted alkoxy, etc.) and / or a terminal connecting functional group (e.g., an amino or carboxylic acid group suitable for attachment via amide bond formation) suitable for connecting the polymer to a molecule of interest (e.g., attached to a light-collecting chromophore via a branching group). The subject water-soluble polymers can be adapted to include any convenient linking group. It will be appreciated that in some cases, the water-soluble polymers may include some dispersity with respect to polymer length, depending on the preparation and / or purification methods of the polymer starting material. In some cases, the water-soluble polymers are monodisperse.
[0034] The water-soluble polymer may include one or more spacers or linkers. Examples of spacers or linkers include linear or branched moieties comprising one or more repeating units used in the water-soluble polymer, diamino and / or diacid units, natural or non-natural amino acids or derivatives thereof, and aliphatic moieties including alkyl, aryl, heteroalkyl, heteroaryl, alkoxy, etc., which may include, for example, up to 18 carbon atoms or even additional polymer chains.
[0035] The water-soluble polymer part or one or more spacers or linkers of the polymer part (if present) can include a biostable or biodegradable polymer chain or unit. For example, polymers with repeating linkers have different degrees of stability under physiological conditions, depending on the instability of the bond. Polymers with such bonds can be classified according to their relative hydrolysis rates under physiological conditions, based on, for example, the known hydrolysis rates of low molecular weight analogs from less stable to more stable (e.g., polyurethane (-NH-C (O)-O)> polyorthoester (-OC ((OR) (R'))-O-)> polyamide (-C (O)-NH)). Similarly, the linker system attaching the water-soluble polymer to the target molecule can be biostable or biodegradable, for example, from less stable to more stable: carbonate (-OC (O)-O)> ester (-C (O)-O)> carbamate (-NH-C (O)-O-)> orthoester (-OC ((OR) (R'))-O-)> amide (-C (O)-NH-). In general, it may be expected to avoid the use of sulfated polysaccharides based on the instability of the sulfate groups. In addition, the use of polycarbonates and polyesters may be less desirable. These bonds are provided as examples only and are not intended to limit the types of bonds that can be employed in the polymer chains or linker systems of the water-soluble polymers useful in the WSG disclosed herein.
[0036] Water-soluble group (WSG) can give theme dye or polymer tandem dye the water solubility that surpasses 10mg / mL, for example surpasses 20mg / mL, surpasses 30mg / mL, surpasses 40mg / mL, surpasses 50mg / mL, surpasses 60mg / mL, surpasses 70mg / mL, surpasses 80mg / mL, surpasses 90mg / mL or surpasses 100mg / mL.In some cases, side chain nonionic water-soluble group (WSG) can give theme dye or polymer tandem dye 20mg / mL or above solubility in water (for example, aqueous buffer), for example 30mg / mL or above, 40mg / mL or above, 50mg / mL or above, 60mg / mL or above, 70mg / mL or above, 80mg / mL or above, 90mg / mL or above, 100mg / mL or above, even more.It is appreciated that the water-soluble dye based on dipyrromethene forms discrete water solvation nanoparticle in aqueous system under certain conditions. In some cases, water-solvated nanoparticles are able to resist aggregation and can be used in a variety of biological assays.
[0037] The terms "polyethylene oxide", "PEO", "polyethylene glycol" and "PEG" are used interchangeably and refer to a polyethylene glycol having the formula --(CH2----O--) n -described chain polymer group or its derivative. In some embodiments, "n" is 5000 or less, such as 1000 or less, 500 or less, 200 or less, 100 or less, 50 or less, 40 or less, 30 or less, 20 or less, 15 or less, such as 3 to 15, or 10 to 15. It should be understood that the PEG polymer group can have any convenient length and can include a variety of terminal groups and / or additional substituents, including but not limited to alkyl, aryl, hydroxyl, amino, acyl, acyloxy and amido terminal and / or substituents. PEG groups that may be suitable for use in the subject multichromophores include those described by S. Zalipsky in “Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates”, Bioconjugate Chemistry 1995, 6(2), 150-165 and by Zhu et al. in “Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy”, Chem. Rev., 2012, 112(8), pp 4687-4735.
[0038] The term "alkyl" by itself or as part of another substituent refers to a saturated branched or straight-chain monovalent hydrocarbon group derived by removing a hydrogen atom from a single carbon atom of a parent alkane. Alkyl groups of interest include, but are not limited to, methyl; ethyl, propyl, such as propane-1-yl or propane-2-yl; and butyl, such as butane-1-yl, butane-2-yl, 2-methyl-propane-1-yl or 2-methyl-propane-2-yl. In some embodiments, the alkyl group comprises 1 to 20 carbon atoms. In some embodiments, the alkyl group comprises 1 to 10 carbon atoms. In certain embodiments, the low alkyl group comprises 1 to 6 carbon atoms, such as 1 to 4 carbon atoms. For example, the term includes straight and branched chain hydrocarbon groups such as methyl (CH3-), ethyl (CH3CH2-), n-propyl (CH3CH2CH2-), isopropyl ((CH3)2CH-), n-butyl (CH3CH2CH2CH2-), isobutyl ((CH3)2CHCH2-), sec-butyl ((CH3)(CH3CH2)CH-), tert-butyl ((CH3)3C-), n-pentyl (CH3CH2CH2CH2CH2-) and neopentyl ((CH3)3CCH2-).
[0039] The term "substituted alkyl" refers to an alkyl group as defined herein in which one or more carbon atoms in the alkyl chain have been optionally replaced by a heteroatom (such as -O-, -N-, -S-), -S(O) n -(wherein n is 0 to 2), -NR-(wherein R is hydrogen or alkyl) and has 1 to 5 substituents selected from alkoxy, substituted alkoxy, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, acyl, acylamino, acyloxy, amino, aminoacyl, aminoacyloxy, oxyaminoacyl, azido, cyano, halogen, hydroxy, oxo, thioketo, carboxyl, carboxylalkyl, thioaryloxy, thioheteroaryloxy, thioheterocyclyloxy, thio, thioalkoxy, substituted thioalkoxy, aryl, aryloxy, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclyloxy, hydroxyamino, alkoxyamino, nitro, -SO-alkyl, -SO-aryl, -SO-heteroaryl, -SO2-alkyl, -SO2-aryl, -SO2-heteroaryl and -NR a R b , wherein R' and R" may be the same or different and are selected from hydrogen, optionally substituted alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, aryl, heteroaryl and heterocycle.
[0040] "Alkoxy" refers to an -O-alkyl group, wherein alkyl is as defined herein. For example, alkoxy includes methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, tert-butoxy, sec-butoxy, n-pentoxy, and the like. The term "alkoxy" also refers to the groups: alkenyl-O-, cycloalkyl-O-, cycloalkenyl-O-, and alkynyl-O-, wherein alkenyl, cycloalkyl, cycloalkenyl, and alkynyl are as defined herein.
[0041] The term "substituted alkoxy" refers to substituted alkyl-O-, substituted alkenyl-O-, substituted cycloalkyl-O-, substituted cycloalkenyl-O-, and substituted alkynyl-O- groups, wherein substituted alkyl, substituted alkenyl, substituted cycloalkyl, substituted cycloalkenyl, and substituted alkynyl are as defined herein.
[0042] "Alkenyl" refers to a monovalent, branched or straight-chain, cyclic or acyclic hydrocarbon group containing a carbon-carbon double bond. Exemplary alkenyl groups include vinyl, n-propenyl, isopropenyl, n-butenyl, isobutenyl, octenyl, decenyl, tetradecenyl, hexadecenyl, eicosene and tetracosene. In some cases, the alkenyl group includes 1 to 24 carbon atoms, such as 1 to 18 carbon atoms or 1 to 12 carbon atoms. The term "lower alkenyl" refers to an alkyl group with 1 to 6 carbon atoms.
[0043] "Alkynyl" or "alkyne" refers to a straight or branched monovalent hydrocarbon radical having 2 to 6 carbon atoms, preferably 2 to 3 carbon atoms, and having at least 1 and preferably 1 to 2 sites of triple bond unsaturation. Examples of such alkynyl radicals include ethynyl (-C≡CH) and propargyl (-CH2C≡CH).
[0044] The term "substituted alkynyl" or "substituted alkyne" refers to an alkynyl group as defined herein having from 1 to 5 substituents, or from 1 to 3 substituents selected from alkoxy, substituted alkoxy, cycloalkyl, substituted cycloalkyl, cycloalkenyl, substituted cycloalkenyl, acyl, acylamino, acyloxy, amino, substituted amino, aminoacyl, aminoacyloxy, oxyaminoacyl, azido, cyano, halogen, hydroxy, oxo, thioketo, carboxy, carboxyalkyl, thioaryloxy, thioheteroaryloxy, thioheterocyclyloxy, thiol, thioalkoxy, substituted thioalkoxy, aryl, aryloxy, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclyloxy, hydroxyamino, alkoxyamino, nitro, -SO-alkyl, -SO-substituted alkyl, -SO-aryl, -SO-heteroaryl, -SO2-alkyl, -SO2-substituted alkyl, -SO2-aryl and -SO2-heteroaryl.
[0045] "Heterocyclyl" refers to a monoradical cyclic group that contains heteroatoms (e.g., O, S, N) as ring atoms and is not aromatic (ie, distinguishing heterocyclyl from heteroaryl). Exemplary heterocyclyl groups include piperidinyl, tetrahydrofuranyl, dihydrofuranyl, and thiocyanato.
[0046] "Amino" refers to a -NH2 group. The term "substituted amino" refers to a -NRR group, wherein each R is independently selected from hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, alkenyl, substituted alkenyl, cycloalkenyl, substituted cycloalkenyl, alkynyl, substituted alkynyl, aryl, heteroaryl, and heterocyclyl, provided that at least one R is not hydrogen.
[0047] "Aryl" by itself or as part of another substituent refers to a monovalent aromatic hydrocarbon radical derived by the removal of one hydrogen atom from a single carbon atom of an aromatic ring system. Aryl groups of interest include, but are not limited to, those derived from aceanthrene, acenaphthene, acephenanthrene, anthracene, azulene, benzene, In some embodiments, the aryl group comprises 6 to 20 carbon atoms. In some embodiments, the aryl group comprises 6 to 12 carbon atoms. Examples of aryl groups are phenyl and naphthyl.
[0048] "Substituted aryl", unless the definition of aryl substituents is otherwise limited, refers to an aryl group substituted with from 1 to 5 substituents, or from 1 to 3 substituents, selected from the group consisting of acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclyloxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioaryloxy, -SO-alkyl, -SO-substituted alkyl, -SO-aryl, -SO-heteroaryl, -SO2-alkyl, -SO2-substituted alkyl, -SO2-aryl, -SO2-heteroaryl, and trihalomethyl.
[0049] "Heteroaryl" by itself or as part of another substituent refers to a monovalent heteroaryl radical derived by the removal of one hydrogen atom from a single atom of a heteroaromatic ring system. Heteroaryl groups of interest include, but are not limited to, those derived from acridine, arsindene, carbazole, β-carboline, chroman, chromene, cinnoline, furan, imidazole, indazole, indole, indoline, indolizine, isobenzofuran, isochromene, isoindole, isoindoline, isoquinoline, isothiazole, isoxazole, naphthyridine, oxadiazole, oxazole, In some embodiments, the heteroaryl group is a group of 1-20 yuan heteroaryl. ...
[0050] "Heterocycle", "heterocyclic", "heterocycloalkyl" and "heterocyclyl" refer to a saturated or unsaturated group having a single ring or multiple fused rings (including fused bridged rings and spiro ring systems) and having 3 to 20 ring atoms (including 1 to 10 heteroatoms). These ring atoms are selected from nitrogen, sulfur or oxygen, wherein, in a fused ring system, one or more rings can be cycloalkyl, aryl or heteroaryl, provided that the point of attachment is through a non-aromatic ring. In certain embodiments, the nitrogen and / or sulfur atoms of the heterocyclic group are optionally oxidized to provide N-oxide, -S(O)- or -SO2- moieties.
[0051] Examples of heterocyclic and heteroaryl groups include, but are not limited to, azetidine, pyrrole, imidazole, pyrazole, pyridine, pyrazine, pyrimidine, pyridazine, indolizine, isoindole, indole, indoline, indazole, purine, quinolizine, isoquinoline, quinoline, phthalazine, naphthylpyridine, quinoxaline, quinazoline, cinnoline, pteridine, carbazole, carboline, phenanthridine, acridine, phenanthroline, isothiazole, phenazine, isoxazole, phenoxazine, phenanthroline, Thiazine, imidazolidine, imidazoline, piperidine, piperazine, indoline, phthalimide, 1,2,3,4-tetrahydroisoquinoline, 4,5,6,7-tetrahydrobenzo[b]thiophene, thiazole, thiazolidine, thiophene, benzo[b]thiophene, morpholinyl, thiomorpholinyl (also known as thiamorpholinyl), 1,1-dioxothiomorpholinyl, piperidinyl, pyrrolidine, tetrahydrofuranyl, and the like.
[0052] "Substituted heteroaryl", unless the definition of substituents is otherwise limited, refers to a heteroaryl group substituted with 1 to 5 substituents, or 1 to 3 substituents, selected from the group consisting of acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclyloxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioaryloxy, -SO-alkyl, -SO-substituted alkyl, -SO-aryl, -SO-heteroaryl, -SO2-alkyl, -SO2-substituted alkyl, -SO2-aryl, -SO2-heteroaryl, and trihalomethyl.
[0053] The term "alkaryl" or "aralkyl" refers to the groups -alkylene-aryl and substituted alkylene-aryl wherein alkylene, substituted alkylene and aryl are as defined herein.
[0054] "Alkylene" refers to a divalent aliphatic hydrocarbon group preferably having 1 to 6 and more preferably 1 to 3 carbon atoms, which is linear or branched and optionally substituted by one or more selected from -O-, -NR- 10 -、-NR 10 C(O)-、-C(O)NR 10 -, etc. By way of example, the term includes methylene (-CH2-), ethylene (-CH2CH2-), n-propylene (-CH2CH2CH2-), isopropylene (-CH2CH(CH3)-), (-C(CH3)2CH2CH2-), (-C(CH3)2CH2C(O)-), (-C(CH3)2CH2C(O)NH-), (-CH(CH3)CH2-), and the like. "Substituted alkylene" refers to an alkylene group having from 1 to 3 hydrogens replaced by substituents as described for the carbon in the definition of "substituted" below.
[0055] "Substituted" refers to a group in which one or more hydrogen atoms are independently replaced by the same or different substituents. Substituents of interest include, but are not limited to, alkylenedioxy (such as methylenedioxy), -MR 60 , -O - ,=O,-OR 60 、-SR 60 , -S - , =S, -NR 60 R 61 , =NR 60, -CF3, -CN, -OCN, -SCN, -NO, -NO2, =N2, -N3, -S(O)2O - 、-S(O)2OH、-S(O)2R 60 、-OS(O)2O - 、-OS(O)2R 60 、-P(O)(O - )2、-P(O)(OR 60 )(O - )、-OP(O)(OR 60 )(OR 61 )、-C(O)R 60 、-C(S)R 60 、-C(O)OR 60 、-C(O)NR 60 R 61 ,-C(O)O - 、-C(S)OR 60 、-NR 62 C(O)NR 60 R 61 、-NR 62 C(S)NR 60 R 61 、-NR 62 C(NR 63 )NR 60 R 61 and -C(NR 62 )NR 60 R 61 , wherein M is halogen; R 60 , R 61 , R 62 and R 63 are independently hydrogen, alkyl, substituted alkyl, alkoxy, substituted alkoxy, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl, or optionally, R 60 and R 61 Together with the nitrogen atom to which they are bound, they form a cycloheteroalkyl or substituted cycloheteroalkyl ring; and R 64 and R 65 R is independently hydrogen, alkyl, substituted alkyl, aryl, cycloalkyl, substituted cycloalkyl, cycloheteroalkyl, substituted cycloheteroalkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl, or optionally R 64 and R 65 Together with the nitrogen atom to which they are bound, they form a cycloheteroalkyl or substituted cycloheteroalkyl ring. In certain embodiments, the substituents include -M, -R 60 ,=O,-OR 60 、-SR60 , -S - , =S, -NR 60 R 61 , =NR 60 , -CF3, -CN, -OCN, -SCN, -NO, -NO2, =N2, -N3, -S(O)2R 60 、-OS(O)2O - 、-OS(O)2R 60 、-P(O)(O - )2、-P(O)(OR 60 )(O - )、-OP(O)(OR 60 )(OR 61 )、-C(O)R 60 、-C(S)R 60 、-C(O)OR 60 、-C(O)NR 60 R 61 、-C(O)O - 、-NR 62 C(O)NR 60 R 61 In certain embodiments, the substituents include -M, -R 60 ,=O,-OR 60 、-SR 60 、-NR 60 R 61 , -CF3, -CN, -NO2, -S(O)2R 60 、-P(O)(OR 60 )(O - )、-OP(O)(OR 60 )(OR 61 )、-C(O)R 60 、-C(O)OR 60 、-C(O)NR 60 R 61 、-C(O)O - In certain embodiments, the substituents include -M, -R 60 ,=O,-OR 60 、-SR 60 、-NR 60 R 61 , -CF3, -CN, -NO2, -S(O)2R 60 、-OP(O)(OR 60 )(OR 61 )、-C(O)R 60 、-C(O)OR 60 、-C(O)O -, where R 60 , R 61 and R 62 As defined above. For example, a substituted group may carry a methylenedioxy substituent or one, two or three substituents selected from halogen atoms, (1-4C)alkyl groups and (1-4C)alkoxy groups. When the substituted group is an aryl or heteroaryl group, the substituent (e.g., as described herein) may be referred to as an "aryl substituent".
[0056] It is understood that, in all of the substituents defined above, polymers obtained by defining a substituent as itself having further substituents (e.g., a substituted aryl having a substituted aryl group as a substituent, which itself is substituted with a substituted aryl group, which is further substituted with a substituted aryl group, etc.) are not intended to be included herein. In this case, the maximum number of such substitutions is three. For example, sequential substitutions of substituted aryl groups specifically contemplated herein are limited to substituted aryl-(substituted aryl)-substituted aryl.
[0057] "Acyl" refers to a group of the formula -C(O)R, where R is alkyl, alkenyl, or alkynyl. For example, an acetyl group has the formula -C(O)CH3.
[0058] "Halo" and "halogen" refer to chloro, bromo, fluoro and iodo radicals.
[0059] "Carboxy," "carboxyl," and "carboxylate" refer to the -CO2H group and its salts.
[0060] "Sulfonyl" refers to a -SO2R group, where R is alkyl, alkenyl, alkynyl, aryl, heteroaryl, heterocyclyl, and substituted forms thereof. Exemplary sulfonyl groups include -SO2CH3 and -SO2(C6H5).
[0061] Unless otherwise specified, a reference to an atom is intended to include all isotopes of that atom. For example, a reference to H is intended to include 1 H. 2 H (i.e. D) and 3 H (i.e. T), and reference to C means including 12 C and all isotopes of carbon (e.g. 13 C) In addition, any group described includes all stereoisomers of that group.
[0062] Unless otherwise indicated, nomenclature for substituents not specifically defined herein is derived by naming the terminal portion of the functionality followed by the adjacent functionality toward the point of attachment. For example, the substituent "arylalkoxycarbonyl" refers to the group: (aryl)-(alkyl)-OC(O)-.
[0063] For any group containing one or more substituents disclosed herein, it is of course understood that such groups do not contain any sterically impractical and / or synthetically unfeasible substitutions or substitution patterns. In addition, the subject compounds include all stereochemical isomers resulting from substitutions of these compounds.
[0064] Details
[0065] A violet excitable tandem dye is provided. The tandem dye of an embodiment of the present invention comprises: a non-conjugated polymer backbone; one or more violet excitable donor fluorophores connected to the non-conjugated polymer backbone; and one or more acceptor fluorophores connected to the non-conjugated polymer backbone; wherein the donor and acceptor fluorophores are in an energy transfer relationship. Also provided are methods for preparing and using the tandem dye, and a kit comprising the dye and being useful in embodiments of the method.
[0066] Before describing exemplary embodiments in greater detail, the following definitions are set forth to illustrate and define the meaning and scope of the terms used in the specification.
[0067] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. Nevertheless, for clarity and ease of reference, certain terms are defined below. In addition, representative illustrative methods and materials are described herein, although any methods and materials similar or equivalent to those described herein may also be used in the practice or testing of the present invention.
[0068] Where a numerical range is provided, it is understood that each intermediate value between the upper and lower limits of the range (unless the context clearly indicates otherwise, up to one tenth of the unit of the lower limit) and any other stated or intermediate value in the stated range are encompassed within the present invention. The upper and lower limits of these smaller ranges may be independently included in the smaller range and are also encompassed within the present invention, but are subject to the impact of any specifically excluded limitations in the stated range. When the stated range includes one or two limits, ranges excluding one or both of the included limits are also encompassed within the present invention.
[0069] Certain ranges of values given herein are preceded by the term "about." The term "about" is used herein to provide literal support for the exact number that follows it, as well as numbers that are close to or approximately the number that follows the term. In determining whether a number is close to or approximately a specifically recited number, the close or approximate unrecited number may be a number that, in the context presented, provides a substantial equivalent to the specifically recited number.
[0070] All publications and patents cited in this specification are incorporated herein by reference as if each individual publication or patent was specifically and individually indicated to be incorporated by reference, and are incorporated herein by reference to disclose and describe the methods and / or materials in connection with the publication cited. Citation of any publication is for its disclosure prior to the filing date and should not be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the publication dates provided may be different from the actual publication dates, which may need to be independently confirmed.
[0071] It should be noted that, as used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. It should also be noted that the claims can be drafted to exclude any optional elements. Thus, this statement is intended to serve as antecedent basis for use of such exclusive terminology as "solely," "only," and the like in connection with the recitation of claim elements, or use of a "negative" limitation.
[0072] As will be apparent to those skilled in the art after reading this disclosure, each of the various embodiments described and illustrated herein has discrete components and features that can be easily separated or combined with the features of any of the other several embodiments without departing from the scope or spirit of the invention. Any described method can be executed in the order of events described or in any other order that is logically possible.
[0073] The apparatus and method have been or will be described for grammatical fluency and functional explanation, but it should be clearly understood that unless expressly stated in accordance with 35 U.S.C. §112, the claims should not be interpreted as being necessarily limited in any way to the interpretation of "means" or "step" limitations, but should be given the full scope of the meaning and equivalents provided by the claims under the doctrine of equivalents, and the case where the claims are expressly stated in accordance with 35 U.S.C. §112 should be given all legal equivalents under 35 U.S.C. §112.
[0074] In further describing various embodiments of the invention, the violet excitable tandem dyes are first reviewed in more detail, followed by methods of using and making the dyes, and a review of kits including the conjugates.
[0075] Violet excitable tandem dye
[0076] As described above, the present disclosure provides a purple excitable fluorescent tandem dye conjugate. Purple excitable tandem dyes are dyes that can be excited by purple light (e.g., purple light provided by a purple laser). In some cases, purple excitable tandem dyes can be excited by light with a wavelength range of 350 to 450 nm. The excitation maximum of the purple excitable tandem dye of the present invention can vary, and in some embodiments, ranges from 375 to 425 nm,, e.g., 390 to 410 nm, e.g., 400 to 410 nm. Therefore, the purple excitable tandem dye of the present invention can be excited by a laser that produces light with a wavelength range of 375 to 425 nm (e.g., 390 to 410 nm, e.g., 400 to 410 nm), wherein examples of such lasers include, but are not limited to: purple laser diodes (e.g., as described in Telford et al., "Violet laser diodes in flow cytometry: an update," Cytometry A. (November 1, 2006) 69 (11): 1153-60), and the like.
[0077] As described above, the purple excitable tandem dye of the embodiment of the present invention comprises: a non-conjugated polymer backbone; one or more purple excitable donor fluorophores connected to the non-conjugated polymer backbone; and one or more acceptor fluorophores connected to the non-conjugated polymer backbone; wherein the donor and acceptor fluorophores are in an energy transfer relationship. Each component of the purple excitable dye will now be reviewed in more detail.
[0078] Violet excitable donor fluorophore
[0079] As described above, the tandem dye of the present invention includes one or more violet excitable donor fluorophores. The violet excitable donor fluorophore is a fluorophore that absorbs violet wavelength range (e.g., 350 to 450nm, e.g., 375 to 425nm) light. In some cases, the maximum absorption range of the violet excitable donor fluorophore is 375 to 425nm, e.g., 390 to 410nm, e.g., 400 to 410nm, e.g., 400nm, 401nm, 402nm, 403nm, 404nm, 405nm, 406nm, 407nm, 408nm, 409nm and 410nm. In certain embodiments, the violet excitable donor fluorophore exhibits a narrow absorption spectrum. A narrow absorption spectrum refers to a narrow absorption spectrum with a full width at half maximum (FWHM) of the maximum absorption peak of 35 nm or less, such as 25 nm or less, 20 nm or less, 15 nm or less, 12 nm or less, or 10 nm or less, such as measured in ethanol or phosphate buffered saline (PBS). The donor violet excitable fluorophores of embodiments of the present invention may vary. The types of donor violet excitable fluorophores that can be found in the tandem dyes of the present invention include, but are not limited to, coumarin fluorophores, pyrene fluorophores, triphenyl fluorophores, and the like.
[0080] In some cases, the violet excitable donor fluorophore is a coumarin fluorophore. A coumarin fluorophore is a fluorophore having a coumarin core, which can be described as a benzene molecule in which two adjacent hydrogen atoms are replaced by a lactone-like chain -=--O-, forming a second six-membered heterocyclic ring that shares two carbons with the benzene ring. The coumarin core can be described by the following structure:
[0081]
[0082] Coumarin donor fluorophores of interest include coumarin derivatives. A "coumarin" derivative refers to a molecule comprising a coumarin core in which one or more of the coumarin core atoms is substituted or conjugated to another moiety. In some cases, a coumarin fluorophore used as a violet excitable donor fluorophore in embodiments of the present invention is described by the following formula:
[0083]
[0084] in:
[0085] R1 is OR1′ or NR2′R3′, wherein R1′, R2′ and R3′ are independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, alkaryl, aralkyl, water-soluble group (WSG) or carboxyalkyl, alkyl optionally substituted with hydroxyl, amino, carboxyl, carboxylate, amide, carbamate, aminoalkyl or water-soluble group (WSG); or R1′ and R2 or R1′ and R3 together form a 5-, 6- or 7-membered ring selected from aryl, heterocyclyl, heteroaryl and heteroaromatic; or R2′, R2, R3′ and R3 independently form at least one 5-, 6- or 7-membered ring selected from aryl, heterocyclyl, heteroaryl and heteroaromatic;
[0086] R2, R3 and R4 are independently selected from hydrogen, halogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl, aryl, alkaryl, aralkyl, carboxyalkyl, aryl, heterocyclyl, heteroaryl and heteroaromatic, alkyl optionally substituted with hydroxy, amino, carboxyl, carboxylate, amide, carbamate or aminoalkyl, any of which may be further substituted, for example with WSG;
[0087] R5 and R6 are independently selected from hydrogen, halogen, alkyl, alkoxy, keto, carboxylate, carboxylate, carbamate, amide, amino, alkylamino, benzimidazolyl, polyether, alkylthio, cyano, nitro, sulfonyl, pyrimidine, purine, wherein any of these groups may be further substituted, for example, by WSG.
[0088] In some cases, the coumarin donor fluorophore of the tandem dyes of the present invention is a coumarin donor fluorophore having one of the following formulas:
[0089]
[0090]
[0091]
[0092] In some cases, the violet excitable donor fluorophore is a pyrene donor fluorophore. A pyrene donor fluorophore is a fluorophore that includes a polycyclic aromatic hydrocarbon (PAH) having four fused benzene rings to form a flat aromatic system. The pyrene core can be described by the following structure:
[0093]
[0094] Pyrene donor fluorophores of interest include pyrene derivatives. A "pyrene" derivative refers to a molecule comprising four fused pyrene benzene rings in which one or more of the pyrene carbon atoms is substituted or conjugated to another moiety. In some cases, the pyrene donor fluorophore present in the tandem dyes of the present invention is described by the formula:
[0095]
[0096] in,
[0097] (a) R1 can be a chemically reactive functional group such as, but not limited to, an activated ester, an activated carbonate, an acyl azide, an acyl halide, or other reactive groups, such as acrylamides, alkyl and aryl azides, alkynes and constrained cyclic alkynes, anhydrides, halides, sulfonates, amines, alcohols, carboxylic acids, haloacetamides, isothiocyanates, and isocyanates; or conjugates of such reactive groups and additional moieties, such as R1 being a short alkyl chain, or a cyclic ring containing or not containing heteroatoms (e.g., nitrogen, oxygen, sulfur, phosphorus), which ring may be substituted or unsubstituted; and
[0098] (b) R2 is a hydrogen atom, a short alkyl chain or a cyclic ring with or without heteroatoms such as nitrogen, oxygen, sulfur, phosphorus or a water-solubilizing group (WSG).
[0099] Examples of pyrene donor fluorophores according to embodiments of the present invention include, but are not limited to:
[0100]
[0101] In some cases, the pyrene donor fluorophore present in the tandem dyes of the present invention is described by the formula:
[0102]
[0103] in,
[0104] (a) R1 can be a chemically reactive functional group such as, but not limited to, an activated ester, an activated carbonate, an acyl azide, an acyl halide, or other reactive groups, such as acrylamides, alkyl and aryl azides, alkynes and constrained cyclic alkynes, anhydrides, halides, sulfonates, amines, alcohols, carboxylic acids, haloacetamides, isothiocyanates, and isocyanates; or conjugates of such reactive groups and additional moieties, such as R1 being a short alkyl chain, or a cyclic ring containing or not containing heteroatoms (e.g., nitrogen, oxygen, sulfur, phosphorus), which ring may be substituted or unsubstituted; and
[0105] (b) R2 and R3 are hydrogen atoms, short alkyl chains or cyclic rings with or without heteroatoms such as nitrogen, oxygen, sulfur, phosphorus or water-soluble groups (WSG).
[0106] In some cases, the pyrene donor fluorophore of the tandem dyes of the present invention is a pyrene donor fluorophore having the formula:
[0107]
[0108] In some cases, the violet excitable donor fluorophore is a triphenyl donor fluorophore. Triphenyl donor fluorophores of interest include donor fluorophores having a triphenyl group core, namely:
[0109]
[0110] In some cases, the triphenyl donor fluorophore is a triarylmethane dye having formula (VI):
[0111]
[0112] In the formula (VI):
[0113] ■ R 33 , R 34 , R 35 and R 36 are the same or different and represent a hydrogen atom or a group selected from an alkyl group, an optionally substituted aryl group, an optionally substituted aralkyl group, and a water-soluble group;
[0114] ■ R 37 , R 38 , R 39 , R 40 , R 41 , R 42 , R 43 and R 44 are the same or different and represent a hydrogen atom or a group selected from the following: alkyl; alkoxy, alkylthio; (di)(alkyl)amino; hydroxyl, mercapto; -nitro, nitroso; -R°-C(X)-X'-, R°-X'-C(X)- or R°-X'-C(X)-X"-, wherein R° represents a hydrogen atom or an alkyl or aryl group or a carboxyl group, and X, X' and X" are the same or different and represent an oxygen or sulfur atom or an alkyl group or NR, wherein R represents a hydrogen atom or an alkyl group; or two adjacent groups R 41 With R 42 or R 42 With R 43 or R 43 With R 44 together to form a fused benzo group.
[0115] In some cases, the triphenyl donor fluorophore of the tandem dyes of the present invention is a pyrene donor fluorophore having the formula:
[0116]
[0117] If desired, the violet excitable donor fluorophore present in the tandem dyes of embodiments of the present invention may be substituted with one or more water soluble groups (WSG), for example as defined above.
[0118] Acceptor Fluorophore
[0119] As described above, the tandem dyes of the present invention include one or more acceptor fluorophores. In some cases, the tandem dyes include a single acceptor fluorophore. In other cases, the tandem dyes include two or more acceptor fluorophores. Any convenient fluorescent dye can be used as an acceptor fluorophore in the polymer tandem dye. The acceptor fluorophore (e.g., each A) can be a small molecule fluorophore. The acceptor fluorophore (e.g., each A) can be a dye molecule selected from rhodamine, perylene, diimide, coumarin, xanthene, cyanine, polymethine, pyrene, thiazine, acridine, dipyrromethene boron difluoride, naphthylimide, phycobiliprotein, dinoflagellate chlorophyll protein, conjugates thereof, and combinations thereof. In certain embodiments, the acceptor fluorophore (A) is a cyanine dye, a xanthene dye, a coumarin dye, a thiazine dye, or an acridine dye. In some cases, the acceptor fluorophore (A) is selected from DY 431, DY 485XL, DY 500XL, DY 610, DY 640, DY654, DY 682, DY 700, DY 701, DY 704, DY 730, DY 731, DY 732, DY 734, DY 752, DY 778, DY782, DY 800, DY 831, Biotium CF 555, Cy 3.5, and diethylaminocoumarin.Fluorescent dyes of interest include, but are not limited to, fluorescein, 6-FAM, rhodamine, Texas Red, tetramethylrhodamine, carboxyrhodamine, carboxyrhodamine 6G, carboxyrhodamine 110, Cascade Blue, Cascade Yellow, coumarin, Cy2, Cy3, Cy3.5, Cy5, Cy5.5, Cy-Chrome, phycoerythrin, PerCP (peridinyl chlorophyll-a protein), PerCP-Cy5.5, JOE (6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein), NED, ROX (5-(and-6)-carboxy-X-rhodamine), HEX, Lucifer Yellow, Marina Blue, Oregon Green 488, Oregon Green 500, Oregon Green 514, Alexa Fluor 350, Alexa Fluor 430, Alexa Fluor 488, Alexa Fluor 532, Alexa Fluor 546, Alexa Fluor 568, Alexa Fluor 594, Alexa Fluor 633, Alexa Fluor 647, Alexa Fluor 660, Alexa Fluor 680, Alexa Fluor 700, 7-amino-4-methylcoumarin-3-acetic acid, BODIPY FL, BODIPY FL-Br.sub.2, BODIPY 530 / 550, BODIPY 558 / 568, BODIPY 564 / 570, BODIPY 576 / 589, BODIPY 581 / 591, BODIPY 630 / 650, BODIPY 650 / 665, BODIPY R6G, BODIPY TMR, BODIPY TR, and conjugates and derivatives thereof. Lanthanide chelates of interest include, but are not limited to, europium chelates, terbium chelates, and samarium chelates. In some embodiments, the polymer tandem dye comprises a multichromophore linked to an acceptor fluorophore selected from Cy3, Cy3.5, Cy5, Cy5.5, Cy7, Alexa488, Alexa647, and Alexa700.In certain embodiments, the polymer tandem dye includes a multichromophore linked to an acceptor fluorophore selected from the group consisting of a Dyomics dye (e.g., DY 431, DY 485XL, DY 500XL, DY 530, DY610, DY 633, DY 640, DY 651, DY 654, DY 682, DY 700, DY 701, DY 704, DY 730, DY 731, DY732, DY 734, DY 752, DY 754, DY 778, DY 782, DY 800, or DY 831), Biotium CF 555, Cy 3.5, and diethylaminocoumarin. In some cases, the acceptor fluorophore (A) is selected from fluorescein, 6-FAM, rhodamine, Texas Red, California Red, iFluor594, tetramethylrhodamine, carboxyrhodamine, carboxyrhodamine 6G, carboxyrhodamine alcohol, carboxyrhodamine 110, Cascade Blue, Cascade Yellow, coumarin, etc. Cy-Chrome, DyLight 350, DyLight 405, DyLight 488, DyLight 549, DyLight 594, DyLight 633, DyLight 649, DyLight 680, DyLight 750, DyLight 800, Phycoerythrin, PerCP (Peridinyl Chlorophyll-a Protein), PerCP-Cy5.5, JOE (6-Carboxy-4′,5′-dichloro-2′,7′-dimethyloxyfluorescein), NED, ROX (5-(and-6)-Carboxy-X-rhodamine), HEX, Lucifer Yellow, Marina Blue, Oregon Green 488, Oregon Green 500, Oregon Green 514, Alexa 350. Alexa 430. Alexa 488. Alexa 532. Alexa 546. Alexa 568. Alexa 594. Alexa 633. Alexa 647、Alexa 660、Alexa 680, 7-amino-4-methylcoumarin-3-acetic acid, FL, FL-Br2, 530 / 550, 558 / 568, 564 / 570, 576 / 589, 581 / 591, 630 / 650, 650 / 665, R6G, TMR, Tr, conjugates thereof and combinations thereof.
[0120] If desired, the acceptor fluorophore present in the tandem dyes of embodiments of the invention may be substituted with one or more water soluble groups (WSG), for example as defined above.
[0121] Polymer backbone
[0122] As described above, the tandem fluorescent dye of the embodiment of the present invention includes a polymer backbone. In some cases, the polymer backbone is composed of non-conjugated repeating units with any convenient configuration (e.g., linear, branched or dendritic polymer configuration). The polymer backbone can be a linear polymer. The polymer backbone can be branched. In some cases, the dye conjugate includes a plurality of pendant donor chromophores, each of which is independently connected to the non-conjugated repeating units of the polymer backbone. The configuration of the pendant group can be realized during or after the polymer backbone synthesis. The addition of the pendant group can be realized in a sequence-specific manner by random configuration, block configuration or by stepwise synthesis, depending on the specific synthesis method used.
[0123] The term "unit" refers to a structural subunit of a polymer. The term "unit" is intended to include monomers, comonomers, coblocks, repeating units, etc. "Repeat unit" is a subunit of a polymer, which is defined by the minimum number of unique structural features required for the unit to be considered a monomer, so that when the unit is repeated n times, the resulting structure describes a polymer or its block. In some cases, a polymer may include two or more different repeating units, for example, when the polymer is a multi-block polymer, a random arrangement of units, or a defined sequence, each block may define a different repeating unit. It should be understood that the arrangement of repeating units or blocks is varied, and in the illustrated formula of the polymer backbone described herein, any convenient linear arrangement of various lengths may be included in the structure of the overall polymer. It should be understood that a polymer may also be represented by a formula represented by the mol% value of each unit in the polymer, and such a formula may represent a variety of arrangements of repeating units, such as random or multi-block polymers or defined residue sequences. In some cases, the repeating unit of a polymer includes a single monomer group. In some cases, the repeating unit of a polymer includes two or more monomer groups, i.e., comonomer groups, such as two, three, four or more comonomer groups. The term "comonomer" or "comonomer group" refers to a structural unit of a polymer, which itself can be part of a repeating unit of the polymer.
[0124] The backbone of the tandem dye can be of any convenient length. In some cases, the specific number of monomer repeat units or segments of the chromophore can fall within the range of 2 to 500,000, such as 2 to 100,000, 2 to 30,000, 2 to 10,000, 2 to 3,000, or 2 to 1,000 units or segments, or such as 5 to 100,000, 10 to 100,000, 100 to 100,000, 200 to 100,000, or 500 to 50,000 units or segments. In some cases, the specific number of monomer repeating units or segments of the backbone may fall within the range of 2 to 1,000, such as 2 to 500, 2 to 100, 3 to 100, 4 to 100, 5 to 100, 6 to 100, 7 to 100, 8 to 100, 9 to 100, or 10 to 100 units or segments. In some cases, the specific number of monomer repeating units or segments of the backbone may fall within the range of 2 to 500, such as 2 to 400, 2 to 300, 2 to 200, or 2 to 100 units or segments. In some cases, the specific number of monomer repeating units or segments of the backbone may fall within the range of 2 to 100 repeating monomer units, such as 2 to 90, 2 to 80, 2 to 70, 2 to 60, 2 to 50, 2 to 40, or 2 to 30 units or segments.
[0125] The polymer backbone may have a random configuration of non-conjugated repeat units. The polymer backbone may include a block or co-block configuration of non-conjugated repeat units. Alternatively, the polymer backbone may include a specific defined sequence of non-conjugated repeat units, such as the amino acid residues of a polypeptide sequence. These configurations may be characterized by polymer segments of the repeat units (e.g., as described herein), which themselves may be repeated throughout the modular scaffold.
[0126] "Non-conjugated" means that at least a portion of the repeat units include saturated backbone groups (e.g., groups having two or more consecutive single covalent bonds) that exclude π conjugation or a delocalized electronic structure extending from one repeat unit to the next along the polymer backbone. It should be understood that even though a repeat unit may not be conjugated to an adjacent repeat unit, such a repeat unit may also include one or more separate unsaturated groups, including unsaturated bonds (e.g., alkenyl or alkynyl unsaturated bonds) and / or aryl or heteroaryl groups, which may be part of the backbone. In some cases, each repeat unit of the polymer backbone includes a side chain that includes a pendant group attached or a chemoselective tag for attachment to a pendant group.
[0127] In certain embodiments of the tandem dye, the polymer backbone is a linear polymer. In some cases, the linear polymer is selected from a peptide, a peptoid, a hydrocarbon polymer, and a PEG polymer. In some cases, the linear polymer is a peptide. In some cases, the linear polymer is a peptoid. In some cases, the polymer is a hydrocarbon polymer. In some other cases, the polymer is a PEG polymer. More details about polymer backbones that can be used in embodiments of the present invention can be found in PCT Application Serial No. PCT / US2019 / 024662 (published as WO2019 / 191482) and PCT Application Serial No. PCT / US2020 / 019510 (published as WO2020 / 222894); the disclosures of these applications are incorporated herein by reference.
[0128] In some cases, the tandem dye includes a linear peptide backbone of 2 to 100 amino acids (e.g., 2 to 90, 2 to 80, 2 to 70, 2 to 60, 2 to 50, 2 to 40, or 2 to 30 amino acids). In some cases, the linear peptide backbone includes 2 or more amino acids, e.g., 5 or more, 10 or more, 15 or more, 20 or more, 25 or more, 30 or more, up to a maximum of 100 amino acids. In some cases, the tandem dye includes a linear peptide backbone of 5 to 30 amino acids (e.g., 5 to 25, 5 to 20, 5 to 15, or 5 to 10 amino acids).
[0129] If desired, the polymer backbone present in the tandem dyes of embodiments of the present invention may be substituted with one or more water soluble groups (WSG) (eg as defined above).
[0130] Other aspects of violet excitable tandem dyes
[0131] The violet excitable polymeric fluorescent tandem dyes of embodiments of the present invention may vary. In some cases, the polymeric fluorescent tandem dyes of embodiments of the present invention include: a polymer backbone; a plurality of violet excitable pendant donor fluorophores, which are independently connected to repeating units of the polymer backbone; and one or more pendant acceptor fluorophores, which are connected to repeating units of the polymer backbone, wherein the pendant donor and acceptor fluorophores are in an energy transfer relationship. Therefore, the polymeric tandem dyes of embodiments of the present invention include one or more pendant donor fluorophores and one or more pendant acceptor fluorophores, which are configured to be close to one or more pendant donor fluorophores to receive energy, for example, both are connected to a common polymer backbone. In some embodiments, a plurality of pendant donor fluorophores are present and are configured to be close to the pendant acceptor fluorophores for energy transfer, wherein in some cases, the range of a plurality of pendant donor fluorophores is 2 to 20, for example, 2 to 15, for example, 2 to 10. The term "pendant group" refers to a side chain group that is connected to the backbone but is not a part of the backbone itself. In embodiments of polymeric tandem dyes, the donor fluorophore is capable of transferring energy to the connected acceptor fluorophore. Therefore, the subject tandem dye includes an acceptor signaling fluorophore connected to receive energy near the donor fluorophore system, that is, near at least one connected donor fluorophore to receive energy. The specific configuration of the pendant group can be determined and controlled by the arrangement of the repeating units of the lower polymer backbone (also referred to as "modular scaffold" herein), and the pendant group is attached to the backbone. The tandem dye can include multiple water-soluble groups, which are attached to any convenient position of the support and / or pendant group, to provide a water-soluble polymer dye. The polymer backbone, i.e., modular scaffold, can be composed of repeating units, which form a polymer backbone with side chain groups, and the pendant group can be attached to the polymer backbone. Repeating units can be arranged into various configurations, to provide a tandem dye with desired spectral characteristics. The distance and arrangement between the covalent attachment sites of the pendant donor fluorophore and the acceptor fluorophore (when present) can be controlled to provide the desired energy transfer process.
[0132] As mentioned above, if necessary, the polymer backbone and / or the pendant fluorophore (i.e., donor and acceptor fluorophores) may include one or more water-soluble groups (WSG). In some cases, WSG is a pendant group directly connected to the polymer backbone, such as a side chain of the polymer backbone. In some cases, WSG is a substituent attached to a pendant donor fluorophore or a pendant acceptor fluorophore. In some cases, each pendant donor fluorophore group is replaced by one or more WSG. As used herein, the terms "water-soluble group", "water-soluble group" and WSG are used interchangeably, and refer to a group or substituent that is fully solvated in an aqueous environment, such as under physiological conditions, and imparts improved water solubility to the molecule to which it is attached. Compared with a control dye lacking WSG, WSG can increase the solubility of a given polymer tandem dye in a solution based on an aqueous solution. The water-soluble group can be any convenient hydrophilic group that is well solvated in an aqueous environment. The solubility of the water-soluble tandem dye of the present disclosure under aqueous conditions makes it particularly suitable for application in a variety of biological assays. Various water-soluble polymer groups can be applicable to the WSG of the subject dye. Any convenient water solubilizing group (WSG) may be included in the dyes described herein to provide increased water solubility, for example as described above.
[0133] As described above, the polymer fluorescent tandem dye of the embodiment of the present invention includes a plurality of pendant donor fluorophores and one or more pendant acceptor fluorophores. In some cases, the number of donor fluorophores exceeds the number of acceptor fluorophores. In certain embodiments of the tandem dye of the present invention, the ratio of donor fluorophores to acceptor fluorophores is selected from 5: 1, 6: 1, 7: 1, 8: 1, 9: 1, 10: 1 and 20: 2. In some cases, the ratio of donor fluorophores to acceptor fluorophores is 5: 1. In some cases, the ratio of donor fluorophores to acceptor fluorophores is 6: 1. In some cases, the ratio of donor fluorophores to acceptor fluorophores is 7: 1. In some cases, the ratio of donor fluorophores to acceptor fluorophores is 8: 1. In some cases, the ratio of donor fluorophores to acceptor fluorophores is 9: 1. In some cases, the ratio of donor fluorophores to acceptor fluorophores is 10: 1.
[0134] As described above, in the polymeric fluorescent tandem dyes of the present invention, the pendant donor and acceptor fluorophores are in an energy transfer relationship. Thus, in embodiments of the present invention, excitation of the donor can result in energy transfer to and emission from the covalently attached acceptor signaling fluorophore. Energy transfer mechanisms between the donor chromophore and the attached acceptor signaling fluorophore include, for example, resonance energy transfer (e.g., (or fluorescence) resonance energy transfer, FRET), quantum charge exchange (Dexter energy transfer), etc. These energy transfer mechanisms can be relatively short distances; that is, the proximity of the chromophores of the light-collecting multi-chromophore system to each other and / or to the acceptor fluorophore provides efficient energy transfer. Under conditions of efficient energy transfer, when the wavelength of the incident light ("pump light") is absorbed by and transferred from the chromophore of the light-collecting chromophore, the emission of the luminescent acceptor fluorophore is more intense than when the luminescent acceptor fluorophore is directly excited by the pump light, and the emission of the acceptor fluorophore can be amplified. "Effective" energy transfer means that 10% or more (e.g., 20% or more or 30% or more, 40% or more, 50% or more) of the energy collected by the donor chromophore is transferred to the acceptor. "Amplification" means that when excited by energy transfer from the donor light-collecting chromophore system, the signal from the acceptor fluorophore is 1.5 times or more than that of directly exciting the acceptor fluorophore with incident light of equal intensity. The signal can be measured using any convenient method. In some cases, a signal of 1.5 times or more refers to the intensity of the emitted light. In some cases, a signal of 1.5 times or greater refers to an increased signal-to-noise ratio. In certain embodiments of tandem dyes, the acceptor fluorophore emission emitted when excited by the chromophore is 1.5 times or more, e.g., 2 times or more, 3 times or more, 4 times or more, 5 times or more, 6 times or more, 8 times or more, 10 times or more, 20 times or more, 50 times or more, 100 times or more, or even greater, compared to direct excitation of the acceptor fluorophore with incident light.
[0135] The tandem dye of the present invention embodiment can have any convenient molecular weight (MW). In some cases, the MW of the tandem dye can be expressed as mean molecular weight. In some cases, the mean molecular weight of the tandem dye is in the range of 500 to 500,000, for example 1,000 to 100,000, 2,000 to 100,000, 10,000 to 100,000 or even mean molecular weight in the range of 50,000 to 100,000 dalton. In some cases, the molecular weight of the polymer fluorescent dye is in the range of 5 to 75kDa, for example 10 to 50kDa, for example 15 to 45kDa.
[0136] As described above, the tandem dye of the embodiment of the present invention is a violet excitable tandem dye. Therefore, the violet excitable tandem dye is a dye that can be excited by violet light (e.g., violet light provided by a violet laser). In some cases, the violet excitable tandem dye can be excited by light with a wavelength range of 350 to 450 nm. The excitation maximum of the violet excitable tandem dye of the present invention can vary, and in some embodiments, ranges from 375 to 425 nm, such as 390 to 410 nm, such as 400 to 410 nm.
[0137] In some cases, when the light-harvesting chromophore is directly excited by incident light, the tandem dye exhibits an effective Stokes shift of 100 nm or more (e.g., 110 nm or more, 120 nm or more, 130 nm or more, 140 nm or more, 150 nm or more, 160 nm or more, 170 nm or more, 180 nm or more, 190 nm or more, 200 nm or more, 250 nm or more). In some cases, the tandem dye has an effective Stokes shift of up to about 300 nm, e.g., 100-300 nm, 100-250 nm, or 100-200 nm.
[0138] The emission of the polymer tandem dye can have a quantum yield of 0.03 or more, e.g., 0.04 or more, 0.05 or more, 0.06 or more, 0.07 or more, 0.08 or more, 0.09 or more, 0.1 or more, 0.15 or more, 0.2 or more, 0.3 or more, or even higher. In some cases, the extinction coefficient of the polymer tandem dye is 5x10 5 cm -1 M -1 or more, e.g. 6x 10 5 cm -1 M -1 or more, 7x 10 5 cm -1 M -1 or more, 8x10 5 cm -1 M -1 or more, 9x10 5 cm -1 M -1 or more, e.g. 1x 10 6 cm -1 M -1 or more, 1.5x 10 6 cm -1 M -1 or more, 2x 10 6 cm -1 M -1 or more, 2.5x 10 6 cm -1 M -1 or more, 3x 10 6 cm -1 M -1 or more, 4x 10 6 cm -1 M -1 or more, 5x 10 6 cm -1 M -1or more, 6x10 6 cm -1 M -1 or more, 7x 10 6 cm -1 M -1 or more or 8x 10 6 cm -1 M -1 More. In some embodiments, the molar extinction coefficient of the polymer tandem dye is 5 x 10 5 M -1 cm -1 In some embodiments, the molar extinction coefficient of the tandem dye is 1 x 10 6 M -1 cm -1 or higher.
[0139] In embodiments, the subject tandem dyes provide brighter fluorescence emission from the acceptor fluorophore than such fluorescent dyes are capable of alone. The brightness of the emission of the polymer tandem dye may be 50 mM -1 cm -1 or more, e.g. 60 mM -1 cm -1 or more, 70mM -1 cm -1 or more, 80mM -1 cm -1 or more, 90mM -1 cm -1 or more, 100mM -1 cm -1 or more, 150mM -1 cm -1 or more, 200mM -1 cm -1 or more, 250mM -1 cm -1 or more, 300mM -1 cm -1 In some cases, the brightness of the emission of the tandem dye is at least 5 times higher than the brightness of the directly excited acceptor fluorophore, such as at least 10 times higher, at least 20 times higher, at least 30 times higher, at least 50 times higher, at least 100 times higher, at least 300 times higher, or even more times higher than the brightness of the directly excited acceptor fluorophore.
[0140] In addition to the above-mentioned properties, the tandem dyes of embodiments of the present invention may also have one or more additional desired spectral characteristics, such as a specific emission maximum wavelength, extinction coefficient, quantum yield, and the like.
[0141] Various emission spectra depend on various factors, such as the selected comonomers, linking groups, substituents and attached acceptor fluorophores comprised by the tandem dye. In some embodiments, the maximum emission wavelength of the tandem dye is in the range of 425 to 900 nm, such as in the range of 450 nm to 900 nm, 475 nm to 900 nm, or 500 nm to 900 nm.
[0142] In some embodiments, a polymeric tandem dye may include a segment of formula (Ia):
[0143]
[0144] in:
[0145] Each M 1 and M 2 Independently unsaturated comonomers (e.g. amino acid residues);
[0146] Each S 1 and S 2 are independently an optional non-conjugated spacer unit;
[0147] Each D 1 Independently for M 1 a linked pendant violet-excitable donor fluorophore (e.g., as described herein);
[0148] Each A 1 Independently for M 2 the attached acceptor fluorophore;
[0149] x is 75 mol% or more; and
[0150] y is 25 mol% or less.
[0151] The first repeating unit (M 1 -S 1 ) and the second repeating unit (M 2 -S 2 ) can be arranged in a random or co-block configuration. In certain cases of formula (Ia), D of the first repeating unit 1 The pendant group includes two or more (e.g., two or three) different types of pendant light absorbing chromophores that together provide a light harvesting multichromophore system. In certain instances of Formula (Ia), D of the first repeating unit 1 The pendant groups are all identical.
[0152] In some cases of Formula (Ia), x is 80 mol% or more, e.g., 85 mol% or more, 90 mol% or more, 95 mol% or more, 96 mol% or more, 97 mol% or more, 98 mol% or more, or 99 mol% or more. In some cases of Formula (Ia), y is 20 mol% or less, e.g., 15 mol% or less, 10 mol% or less, 5 mol% or less, 4 mol% or less, 3 mol% or less, 2 mol% or less, 1 mol% or less.
[0153] In some cases, the polymeric tandem dye includes a segment of formula (IIa):
[0154]
[0155] in:
[0156] The polymer backbone of the non-conjugated repeating unit comprises SM 1 , SM 2 and SM 3 comonomers, each of which is independently a non-conjugated comonomer;
[0157] Each D 1 Independently for SM 1 a linked pendant violet-excitable donor fluorophore (e.g., as described herein);
[0158] Each A 1 Independently for SM 2 the attached acceptor fluorophore;
[0159] Each Z 2 Independently for SM 3 attached optional side chain groups;
[0160] x is 50 mol% or more; and
[0161] y+z is 50 mol% or less.
[0162] Z 2 may be absent or any convenient side chain group, such as a light absorbing chromophore, a chemoselective tag, a linker, a linked biomolecule, an acceptor fluorophore, WSG (e.g., as described in PCT Application Serial No. PCT / US2019 / 024662 (published as WO 2019 / 191482), the disclosure of which is incorporated herein by reference), etc. In certain cases of Formula (IIa), when Z 2 When it does not exist, SM 3 is a spacer comonomer. In certain cases of formula (IIa), SM 3 It contains Z 2The Z 2 The group is a second pendant light absorbing chromophore, wherein each D 1 and each Z 2 Together they provide a light harvesting multichromophore system. In some cases, the SM 3 is a second chemoselective tag (Z 2 ) comonomers, for example, to provide a protected functional group for selective installation of a moiety of interest or to 1 Orthogonal labels.
[0163] In some cases of formula (IIa), x is 60mol% or more, for example 65mol% or more, 70mol% or more, 75mol% or more, 80mol% or more, 85mol% or more, 90mol% or more, 95mol% or more or even more. In some cases of formula (IIa), y+z is 40mol% or less, for example 30mol% or less, 25mol% or less, 20mol% or less, 15mol% or less, 10mol% or less, 5mol% or less, even less. In some cases of formula (IIa), y is at least 1mol% and 25mol% or less, for example 20mol% or less, 15mol% or less, 10mol% or less, 5mol% or less, even less. In some cases of formula (IIa), z is at least 1mol% and 10mol% or less, for example 5mol% or less, even less.
[0164] In some cases, the polymer tandem dye includes a segment of formula (IIIa):
[0165]
[0166]
[0167] in:
[0168] The polymer backbone of the non-conjugated repeating unit comprises SM 1 and SM 2 comonomers, each of which is independently a non-conjugated comonomer;
[0169] Each D 1 Independently for SM 1 a linked pendant violet-excitable donor fluorophore (e.g., as described herein);
[0170] Each A 1 Independently for SM 2 the attached acceptor fluorophore;
[0171] x is 75 mol% or more; and
[0172] y is 25 mol% or less.
[0173] In certain embodiments of Formula (IIIa), SM 1 and SM 2 Each is independently a saturated non-conjugated comonomer, for example, a comonomer that provides only a single covalent CC bond. In some embodiments of Formula (IIIa), SM 1 and SM 2 Each is independently a saturated non-conjugated comonomer, for example, a comonomer that provides a single double C=C covalent bond in the saturated covalent bond backbone. The first and second repeating units (SM 1 and SM 2 ) can be arranged in a random configuration, a block or co-block configuration or in a specific order. In certain cases of formula (IIIa), SM 1 D 1 The pendant group includes two or more (e.g., two or three) different types of pendant light absorbing chromophores that together provide a light harvesting multichromophore system. In certain instances of formula (IIIa), D of the first repeating unit 1 The pendant groups are all identical.
[0174] In some cases of formula (IIIa), x is 80 mol% or more, for example 85 mol% or more, 90 mol% or more, 95 mol% or more, 96 mol% or more, 97 mol% or more, 98 mol% or more, or 99 mol% or more. In some cases of formula (IIIa), y is 20 mol% or less, for example 15 mol% or less, 10 mol% or less, 5 mol% or less, 4 mol% or less, 3 mol% or less, 2 mol% or less, 1 mol% or less.
[0175] In some cases, the polymeric tandem dye has formula (IVa):
[0176]
[0177] in:
[0178] Each D 1 independently a pendant violet excitable donor fluorophore (e.g., as described herein);
[0179] Each A 1 independently for the acceptor fluorophore;
[0180] Each L 1 and L 2 independently a joint;
[0181] p1 and q1 are independently 0 or 1, where p1+q1≤1;
[0182] p2 and q2 are independently 0 or 1, where p1+q1≤1;
[0183] x is 75 mol% or more;
[0184] y is 25 mol% or less; and
[0185] G 1 and G 2 Each is independently selected from a terminal group, a polymer segment, a light absorbing (eg, donor) chromophore group, an acceptor fluorophore, a linker, and a linker to a specific binding member, for example as described above.
[0186] In some embodiments of Formula (IVa), p1 and p2 are each 0, and q1 and q2 are each 1 (e.g., a β3-amino acid residue). In some embodiments of Formula (IVa), p1 and p2 are each 1, and q1 and q2 are each 0 (e.g., a β2-amino acid residue). In some cases, p1, p2, q1, and q2 are each 0, and the polymer tandem dye has Formula (Va):
[0187]
[0188] in:
[0189] Each D 1 independently a pendant violet excitable donor fluorophore (e.g., as described herein);
[0190] Each A 1 independently for the acceptor fluorophore;
[0191] L 1 and L 2 Each independently is a connector;
[0192] x is 75 mol% or more;
[0193] y is 25 mol% or less; and
[0194] G 1 and G 2 Each is independently selected from end groups, polymer segments, light absorbing (e.g. donor) chromophore groups, linkers and linkers to specific binding members, such as described above. It will be appreciated that the tandem dyes described by formula (Va) include any convenient arrangement of comonomers in a defined linear sequence, these monomers having a total of defined x and y mol%. In some cases, the A-containing 1 The comonomers of D1 are spaced throughout the polymer backbone sequence so that there is always one or more D1-containing comonomers on both sides.
[0195] In certain instances of Formula (Va), the polymeric tandem dye comprises a segment of Formula (VIa):
[0196]
[0197] in:
[0198] Each D 1 independently a pendant violet excitable donor fluorophore (e.g., as described herein);
[0199] Each A 1 independently for the acceptor chromophore;
[0200] Each L 1 and L 2 independently a joint;
[0201] n and p are each independently an integer from 1 to 20, wherein n+p≥2; and
[0202] m is 1 or 2.
[0203] In some instances of Formula (VIa), n and p are each independently 1 to 10, e.g., 2 to 20, 3 to 10, or 3 to 6. In some instances of Formula (VIa), n+p is an integer from 2 to 20, e.g., 3 to 20, 4 to 20, 5 to 20, 5 to 15, or 5 to 12. In certain embodiments of Formula (VIa), m is 1.
[0204] The subject polymer tandem dye may include multiple segments of formula (VIa), wherein each segment includes two D-containing 1 A single comonomer block containing A 1 In some cases, the multichromophore includes two or more segments of formula (VIa) adjacent to each other to provide a copolymer containing 2-20 D 1 The blocks of comonomers (e.g., 3 to 20, 4 to 20, 5 to 20, 5 to 15 or 5 to 12 containing D 1 Two separate A-containing blocks separated by 1 Comonomer. Thus, in certain embodiments, the polymer tandem dye comprises q segments of a block copolymer and has formula (VIIa):
[0205]
[0206] Where: Each (n) q and each (p) q are independently integers from 1 to 20, wherein for each of the q segments, (n) q +(p) q≥3; and q is an integer from 1 to 100.
[0207] In certain embodiments, the polymer tandem dye has formula (VIIIa):
[0208]
[0209] in
[0210] Each D 1 independently a pendant violet excitable donor fluorophore (e.g., as described herein);
[0211] Each A 1 independently for the acceptor chromophore;
[0212] Each L 1 and L 2 independently a joint;
[0213] x is 75 mol% or more;
[0214] y is 25 mol% or less; and
[0215] G 1 and G 2 Each is independently selected from a terminal group, a polymer segment, a donor chromophore group, a linker and a linker to a specific binding member, for example as described above.
[0216] In certain embodiments, the polymeric tandem dye has Formula (IXa):
[0217]
[0218] in:
[0219] Each D 1 independently a pendant violet excitable donor fluorophore (e.g., as described herein);
[0220] Each A 1 independently for the acceptor fluorophore;
[0221] Each L 1 and L 2 independently a joint;
[0222] x is 75 mol% or more;
[0223] y is 25 mol% or less; and
[0224] G 1 and G 2 Each is independently selected from a terminal group, a polymer segment, a donor chromophore group, an acceptor fluorophore group, a linker and a linker to a specific binding member, for example as described above.
[0225] In some cases of Formula (IVa), (Va), (XIIIa) and (IXa), x is 80 mol% or more, e.g., 85 mol% or more, 90 mol% or more, 95 mol% or more, 96 mol% or more, 97 mol% or more, 98 mol% or more, or 99 mol% or more. In some cases of Formula (IV), (V), (XIII) and (IX), y is 20 mol% or less, e.g., 15 mol% or less, 10 mol% or less, 5 mol% or less, 4 mol% or less, 3 mol% or less, 2 mol% or less, 1 mol% or less.
[0226] In certain embodiments, the polymeric tandem dye has formula (Xa):
[0227]
[0228] in:
[0229] Each D 1 independently a pendant violet excitable donor fluorophore (e.g., as described herein);
[0230] Each A 1 independently for the acceptor fluorophore;
[0231] Each L 1 , L 2 and L 3 independently a joint;
[0232] a, b and c are the mol% values of each comonomer;
[0233] d represents the overall degree of polymerization or average length of the polymer (e.g., d is 2-1000, such as 2-500, 2-200, 2-100 or 2-50);
[0234] WSG is a water-soluble group (e.g., as described above and in PCT Application Serial No. PCT / US2019 / 024662 (published as WO 2019 / 191482), the disclosure of which is incorporated herein by reference); and
[0235] G 1 and G 2 Each is independently selected from a terminal group, a polymer segment, a donor chromophore group, an acceptor fluorophore group, a linker and a linker to a specific binding member, for example as described above.
[0236] In some cases of formula (Xa), c=0. In some cases of formula (Xa), a>0 and b>0. In some cases of formula (Xa), a is 80mol% or more, such as 85mol% or more, 90mol% or more, 95mol% or more, 96mol% or more, 97mol% or more, 98mol% or more, or 99mol% or more. In some cases of formula (Xa), b is 20mol% or less, such as 15mol% or less, 10mol% or less, 5mol% or less, 4mol% or less, 3mol% or less, 2mol% or less, 1mol% or less. In some cases of formula (Xa), a is 65-95mol%, b is 5-35mol% and c is 0-30mol%, wherein a+b+c=100%.
[0237] Any convenient end group (e.g., G 1 and G 2 ) can be used at the end of the tandem fluorescent dye. As used herein, the terms "end group" and "terminal group" are used interchangeably to refer to a group located at the end of a tandem dye polymer structure, such as described herein. 1 and G 2 Groups include, but are not limited to, H, chemoselective groups, linkers (which may be activated or inactivated), and linkers conjugated to specific binding members, such as described above. It is understood that the G located at the polymer backbone 1 and / or G 2 The linker at the position of G can be selected to be orthogonal to any other linker that may be present in the tandem dye side chain, including a chemoselective tag (e.g., as described herein). 1 and / or G 2 The position includes an amino functional group or a derivative thereof. In certain embodiments, G 1 and / or G 2 The position includes a carboxylic acid functional group or a derivative thereof.
[0238] In some embodiments of the formulae described herein, G 1 and G 2 At least one of the bits is -L 6 -Z 4 , where L 6 is a linker (eg, as described herein) and Z 4 is a specific binding member (e.g., as described herein). In some embodiments of the formulae described herein, G 1 and G 2 At least one of the bits is -L 6 -Z 3 , where L 6is a linker (eg, as described herein) and Z 3 is a chemoselective tag (e.g., as described herein). Any convenient chemoselective tag and conjugation chemistry may be suitable for use with the subject light-harvesting chromophore. Chemoselective tags of interest include, but are not limited to, amines, active esters, maleimides, thiols, sulfur (VI) fluoride exchange chemistry (SuFEX), sulfonyl fluorides, Diers Alder cycloaddition click reagents and click chemistry, tetrazines, trans-cyclooctenes, aldehydes, alkoxyamines, alkynes, cyclooctynes, azides, and the like. In some cases, Z 3 is selected from carboxylic acids, active esters (e.g., N-hydroxysuccinimide esters (NHS) or sulfo-NHS), amino groups, maleimides, iodoacetyl groups, and thiols. In certain embodiments of the formulae described herein, G 1 and G 2 At least one of is described by the following structure:
[0239] *-Ar-LZ
[0240] wherein Ar is a π-conjugated aromatic group, L is a linker, and Z is a chemoselective tag or a specific binding member. In some cases, the LZ group can be directly attached to a terminal comonomer. In certain embodiments of the formula described herein, G 1 and G 2 At least one of is described by the following structure:
[0241]
[0242] in:
[0243] q is 0 or an integer from 1 to 12;
[0244] L is an optional linker; and
[0245] Z is a chemoselective tag or a specific binding member. More detailed information about the WSG group that can be found in the tandem dyes of embodiments of the present invention can be found in PCT application serial number PCT / US2019 / 024662 (published as WO 2019 / 191482), the disclosure of which is incorporated herein by reference.
[0246] According to one embodiment of the present invention, a representative violet excitable polymer fluorescent tandem dye has the following structure:
[0247]
[0248] As can be seen, the above-mentioned violet excitable polymer tandem dye includes sixteen violet excitable donor coumarin fluorophores flanked by a single acceptor fluorophore (eight donors on each side), wherein the tandem dye is conjugated to an antibody to specifically bind to a target analyte of interest. The violet excitable coumarin donor fluorophore is substituted with a PEG water-soluble group, and the peptide backbone includes a water-soluble PEG spacer between the peptide and the terminal linked antibody.
[0249] method
[0250] Aspects of the present invention include methods for assessing the presence of target analytes in samples. Aspects of the method include contacting sample with a specific binding member of a label of a target analyte that is specifically bound to produce a determination composition comprising a sample contacted with a specific binding member of a label. The specific binding member of the label used in the embodiment of the method of the present invention includes a specific binding member conjugated with a purple excitable polymer fluorescent tandem dye, such as described above. In the following sections, the target analyte may be a target molecule of interest or a reagent (such as an antibody) bound to a target molecule, depending on whether the specific binding member of the label is used as a primary antibody or a secondary antibody. Any convenient method may be used to contact a sample with a specific binding member of a label that is specifically bound to a target analyte, to produce a determination composition. In some cases, the sample is contacted with a specific binding member of a label under the condition that the specific binding member of the label specifically binds to the target analyte (if present). In order to specifically bind the specific binding member of the label to the target analyte, an appropriate medium may be used to maintain the biological activity of sample components and single domain antibodies. The culture medium can be a balanced salt solution, such as physiological saline, PBS, Hank's balanced salt solution, etc., which is conveniently supplemented with fetal bovine serum, human platelet lysate or other factors, combined with an acceptable buffer at a low concentration such as 5-25mM. Convenient buffers include HEPES, phosphate buffer, lactate buffer, etc. Various media are commercially available and can be used according to the properties of the target analyte, including dMEM, HBSS, dPBS, RPMI, Iscove's media, etc., which are supplemented with fetal bovine serum or human platelet lysate in some cases. The final component of the culture medium (which can be a solution) can be selected according to the components of the sample included. The temperature at which the specific binding members of the label are specifically bound to the target analyte can vary, and in some cases can be within the range of 5°C to 50°C, such as 10°C to 40°C, 15°C to 40°C, 20°C to 40°C, such as 20°C, 25°C, 30°C, 35°C or 37°C (for example, as described above). In some cases, the temperature at which specific binding occurs is selected to be compatible with the biological activity of a specific binding member and / or a target analyte. In some cases, the temperature is 25°C, 30°C, 35°C or 37°C. In some cases, the temperature at which specific binding occurs is room temperature (e.g., 25°C), 30°C, 35°C or 37°C. Any convenient incubation time for specific binding can be selected to allow the formation of a desired amount of binding complex, and in some cases, can be 1 minute (min) or longer, such as 2min or longer, 10min or longer, 30min or longer, 1 hour or longer, 2 hours or longer or even 6 hours or longer.
[0251] Any convenient specific binding member can be utilized in the specific binding members of the mark adopted in the method of the present invention. Interested specific binding members include but are not limited to those specific engagement members of the cell surface proteins that specifically bind to a variety of cell types, and the cell type includes but is not limited to stem cells, such as pluripotent stem cells, hematopoietic stem cells, T cells, T regulatory cells, dendritic cells, B cells such as memory B cells, antigen-specific B cells, granulocytes, leukemia cells, lymphoma cells, viral cells (such as HIV cells), NK cells, macrophages, monocytes, fibroblasts, epithelial cells, endothelial cells and erythrocytes. Interested target cells include cells with convenient cell surface markers or antigens that can be captured by convenient specific binding members conjugates. In some embodiments, target cells are selected from cells containing HIV, Treg cells, antigen-specific T cell colonies, tumor cells or hematopoietic progenitor cells (CD34+) from whole blood, bone marrow or umbilical cord blood. Any convenient cell surface protein or cell marker can be targeted and specifically bound to the conjugate used in the subject method. In some embodiments, target cells include cell surface markers selected from cell receptors and cell surface antigens. In some cases, the target cells can include cell surface antigens such as CD11b, CD123, CD14, CD15, CD16, CD19, CD193, CD2, CD25, CD27, CD3, CD335, CD36, CD4, CD43, CD45RO, CD56, CD61, CD7, CD8, CD34, CD1c, CD23, CD304, CD235a, T cell receptor α / β, T cell receptor γ / δ, CD253, CD95, CD20, CD105, CD117, CD120b, Notch4, Lgr5 (N terminus), SSEA-3, TRA-1-60 antigen, disialylganglioside GD2, and CD71.
[0252] Any convenient target can be selected to utilize the subject method for assessment. Interested targets include but are not limited to nucleic acids, such as RNA, DNA, PNA, CNA, HNA, LNA or ANA molecules, proteins such as fusion proteins, modified proteins, such as phosphorylation, glycosylation, ubiquitination, SUMOylation or acetylated proteins, or antibodies, peptides, aggregated biomolecules, cells, small molecules, vitamins and drug molecules. As used herein, the term "target protein" refers to all members of the target family and fragments thereof. Target protein can be any protein of interest, such as treatment or diagnosis targets, including but not limited to: hormones, growth factors, transcription factors, receptors, enzymes, cytokines, osteoinductive factors, colony stimulating factors and immunoglobulins. The term "target protein" is intended to include recombinant and synthetic molecules, which can be prepared using any convenient recombinant expression method or using any convenient synthesis method, or commercial purchase. In some embodiments, the polymer dye conjugate includes an antibody or an antibody fragment. In the subject method, any convenient target analyte that can be targeted specifically combined with an antibody of interest or an antibody fragment.
[0253] In some embodiments, the target analyte is associated with a cell. In some cases, the target analyte is a cell surface marker of a cell. In some cases, the cell surface marker is selected from a cell receptor and a cell surface antigen. In some cases, the target analyte is an intracellular target, and the method further includes processing cells, such as by permeabilizing or lysing the cells, so that the specific binding members of the mark can be close to the intracellular target. Therefore, the specific binding members of the mark used in the method of the present invention can target cell surface or intracellular antigen. Alternatively, the specific binding members of the mark used in the method of the present invention can target an antibody, and the antibody specifically binds to the target cell surface or intracellular antigen.
[0254] In some embodiments, the sample may include a heterogeneous cell population from which a target cell is isolated. In some cases, the sample includes peripheral whole blood, peripheral whole blood in which red blood cells have been lysed before cell separation, cord blood, bone marrow, density gradient purified peripheral blood mononuclear cells or homogenized tissue. In some cases, the sample includes hematopoietic progenitor cells (e.g., CD34+ cells) in whole blood, bone marrow or cord blood. In certain embodiments, the sample includes tumor cells in peripheral blood. In some cases, the sample includes (or is suspected of including) viral cells (e.g., HIV).
[0255] The specific binding members of labeling can be used in the subject method, for example, with polymer series fluorescent dye labeling target cell, particle, target or analyte.For example, the specific binding members of labeling can be used for labeling the cell that will be processed (for example, detection, analysis and / or sorting) in flow cytometer.The specific binding members of labeling can include specific binding members, such as antibody or its binding fragment, which specifically binds to the cell surface protein (for example, as described herein) of for example various cell types.The specific binding members of labeling can be used for studying various biological (for example cell) characteristics or processes, for example cell cycle, cell proliferation, cell differentiation, DNA repair, T cell signaling, apoptosis, cell surface protein expression and / or presentation etc.The specific binding members of labeling can be used for including (or can include) any application of antibody-mediated labeling of cell, particle or analyte.
[0256] Aspects of the method include determining whether there is a labeled specific binding member-target analyte binding complex in the assay composition (i.e., the sample contacted by the labeled specific binding member) to assess whether the target analyte is present in the sample. Once the sample contacts the labeled specific binding member, any convenient method can be used to determine the produced assay composition to determine the presence of the labeled specific binding member-target analyte binding complex. The labeled specific binding member-target analyte binding complex is a binding complex produced when the labeled specific binding member and (if present) target analyte (or the main binding member for the target antigen, for example, a primary antibody, depending on the embodiment) are specifically bound. Determining the assay composition may include detecting a fluorescent signal from the binding complex. In some cases, the assay includes a separation step in which the target analyte (if present) is separated from the sample. A variety of methods can be used to separate the target analyte from the sample, for example, by being fixed on a support. Interested assay methods include but are not limited to any convenient method and assay format for using a specific binding member such as avidin-biotin or hapten-antihapten antibodies. Methods and assay formats of interest that may be suitable for use with the subject compositions include, but are not limited to, flow cytometry methods, in situ hybridization methods, enzyme-linked immunosorbent assays (ELISAs), Western blot analysis, magnetic cell separation assays, and fluorescent dye purification chromatography.
[0257] In certain embodiments, the method also includes contacting the sample with the second specific binding members of the specific binding target analyte. In some cases, the second specific binding members is a support bond. Any convenient support can be used to fix the component (for example, the second specific binding members) of the subject method. In some cases, the support is a particle, such as a magnetic particle. In some cases, the second specific binding members and the polymer dye conjugate produce a sandwich complex, and any convenient method can be used to separate and detect the sandwich complex (if present). In some embodiments, the method also includes the target analyte binding complex of the polymer dye conjugated by flow cytometry, i.e., fluorescently labeled target analyte. The presence of the specific binding member-target analyte binding complex of the assay mark can provide a determination result (for example, qualitative or quantitative determination data), which can be used to assess whether there is a target analyte in the sample.
[0258] In the subject method, any convenient support can be used to fix any convenient component of the method, such as the specific binding members, targets, second specific binding members of the labeling, etc. The support of interest includes but is not limited to: solid matrix, wherein the matrix can have a variety of structures, such as sheets, beads or other structures, such as plates with holes; beads, polymers, particles, fiber nets, hydrogels, porous substrates, pins, microarray surfaces, chromatographic supports, etc. In some cases, the support is selected from particles, planar solid substrates, fiber nets, hydrogels, porous substrates, pins, microarray surfaces and chromatographic supports. The support can be incorporated into the system, which provides the cell separation assisted by any convenient method (such as manually operated syringes, centrifuges or automatic liquid handling systems). In some cases, the support can be used for automated liquid handling systems, to achieve high-throughput separation of cells, such as flow cytometers.
[0259] In some embodiments of the method, the separation step includes applying an external magnetic field to fix the magnetic particles. Any convenient magnet can be used as the source of an external magnetic field (e.g., magnetic field gradient). In some cases, the external magnetic field is produced by a magnetic source, such as produced by a permanent magnet or an electromagnet. In some cases, fixing the magnetic particles means that the magnetic particles are gathered near the surface closest to the magnetic field gradient source (i.e., magnet).
[0260] Separation can also comprise one or more optional washing steps to remove the unbound material of sample from support.Any convenient washing method can be used, for example, with biocompatible buffer solution washing immobilized support, which retains the specific binding interaction of polymer dye and specific binding member.Separating and optionally cleaning the unbound material of sample from support provides the target cell group of enrichment, wherein can remove unwanted cells and material.
[0261] In certain embodiments, the method includes detecting a labeled target analyte. Detecting a labeled target analyte can include exciting a polymer fluorescent tandem dye with one or more lasers, and then using one or more optical detectors to detect the fluorescence emission from the polymer fluorescent tandem dye. The detection of the labeled target can be carried out using any convenient instrument and method, including but not limited to flow cytometry, FACS system, fluorescence microscopy; using a microplate reader for fluorescence, cold light, ultraviolet light and / or visible light detection; high performance liquid chromatography (HPLC); and mass spectrometry. When using fluorescently labeled components in the methods and compositions of the present disclosure, it is recognized that different types of fluorescence detection systems can be used to practice the subject method. In some cases, high throughput screening can be performed, such as a system using 96 wells or larger microtiter plates. A variety of methods for measuring fluorescent materials can be used, such as those described in Lakowicz, JR, Principles of Fluorescent Spectroscopy, New York: Plenum Press (1983); Herman, B., Resonance energy transfer microscopy, in: Fluorescence Microscopy of Living Cells in Culture, Part B, Methods in Cell Biology, vol. 30, ed. Taylor, DL & Wang, Y.-L., San Diego: Academic Press (1989), pp. 219-243; Turro, NJ, Modern Molecular Photochemistry, Menlo Park: Benjamin / Cummings Publishing Col, Inc. (1978), pp. 296-361.
[0262] Fluorescence in a sample can be measured using a fluorometer. In some cases, excitation radiation from an excitation source having a first wavelength passes through an excitation optical device. The excitation optical device causes the excitation radiation to excite the sample. In response, the fluorescently labeled target in the sample emits radiation having a wavelength different from the excitation wavelength. The collection optical device then collects the emitted light from the sample. The device may include a temperature controller to keep the sample at a specific temperature while scanning the sample. In some cases, a multi-axis translation stage moves a microtiter plate holding multiple samples in order to locate different wells to be exposed. The multi-axis translation stage, temperature controller, autofocus function, and electronic devices associated with imaging and data collection can be programmed by a properly programmed digital computer. The computer can also convert the data collected during the assay into another format for presentation.
[0263] In some embodiments, the method for assessing the presence of a target analyte in a sample further comprises detecting fluorescence in a flow cytometer. In some embodiments, the method for assessing the presence of a target analyte in a sample further comprises imaging the sample contacted with the labeling composition using fluorescence microscopy. Fluorescence microscopy imaging can be used to identify polymer dye conjugate-target analyte binding complexes in the contacted sample to assess whether the target analyte exists. Microscopic methods of interest that can be used for the subject method include laser scanning confocal microscopy.
[0264] Also provided is a method for producing a purple excitable polymer fluorescent tandem dye, for example as described herein. In some embodiments, the method includes: contacting a specific binding member with a purple excitable polymer fluorescent tandem dye (for example as described herein) to produce a specific binding member / polymer fluorescent tandem dye conjugate, wherein the polymer fluorescent tandem dye includes a conjugated label that the dye is covalently connected to a specific binding member. The term "conjugated label" refers to a group including a chemoselective functional group (for example, as described herein), which can be covalently connected to a compatible functional group of a specific binding member after optional activation and / or deprotection. Any convenient conjugated label can be used in the subject polymer dye so that the polymer fluorescent tandem dye is conjugated to a specific binding member (for example, an antibody or fragment thereof of interest). In some embodiments, the conjugated label includes a terminal functional group selected from amino, carboxylic acid or derivatives thereof, thiol, hydroxyl, hydrazine, hydrazide, azide, alkyne and protein reactive groups (for example, amino reactive, thiol reactive, hydroxy reactive, imidazole reactive or guanidinyl reactive). Any convenient method and reagent can be applied to the subject method so that the conjugated label is covalently connected to a specific binding molecule. The method of interest for marking the target includes but is not limited to those methods and reagents described by Hermanson, Bioconjugate Techniques, 3rd edition, Academic Press, 2013. The contact step can be carried out in an aqueous solution. In some cases, the conjugated label includes an amino functional group and the target molecule includes an activated ester functional group, such as NHS ester or sulfo-NHS ester, or vice versa. In some cases, the conjugated label includes a maleimide functional group and the target molecule includes a thiol functional group, or vice versa. In some cases, the conjugated label includes an alkyne (e.g., cyclooctyne group) functional group and the target molecule includes an azide functional group, or vice versa, which can be conjugated by click chemistry. In some cases, the method includes a separation step, wherein the specific binding member of the product label is separated from the reaction mixture (e.g., excess reagent or unlabeled specific binding member). A variety of methods can be used to separate the target from the sample, such as by being fixed on a support, precipitation, chromatography, etc.
[0265] In some cases, the method also includes the specific binding members of detection and / or analysis product labeling. In some cases, the method also includes the specific binding members of fluorescence detection labeling. Any convenient method can be used to detect and / or analyze specific binding members in conjunction with subject method and composition. The method for analyzing the target of interest that can be used for subject method includes but is not limited to flow cytometry, fluorescence microscopy, in situ hybridization, enzyme-linked immunosorbent assay (ELISA), Western blot analysis, magnetic cell separation assay and fluorescent dye purification chromatography. Interested detection methods include but are not limited to fluorescence spectroscopy, fluorescence microscopy, nucleic acid sequencing, fluorescence in situ hybridization (FISH), protein mass spectrometry, flow cytometry, etc.
[0266] Detection can be achieved directly by polymerizing tandem dyes, or indirectly by auxiliary detection systems. The latter can be based on any one or a combination of several different principles, including but not limited to antibody-labeled anti-species antibodies and other forms of immunological or non-immunological bridging and signal amplification systems (e.g., biotin-streptavidin technology, protein A and protein G-mediated technology, or nucleic acid probes / anti-nucleic acid probes, etc.). Suitable reporter molecules can be those molecules known in the field of immunocytochemistry, molecular biology, light, fluorescence and electron microscopy, cell immunophenotype, cell sorting, flow cytometry, cell visualization, detection, counting and / or signal output quantification. More than one specific and / or nonspecific antibodies can be labeled and used simultaneously or sequentially to promote target detection, identification and / or analysis.
[0267] system
[0268] Aspects of the present invention further include systems for practicing subject methods and compositions. The sample analysis system may include a sample field of view or a flow channel containing a sample and a labeled specific binding member of the present invention, such as described above. In some embodiments, the system is a flow cytometry system, including: a flow cytometer comprising a flow path; a composition in the flow path, wherein the composition comprises: a sample and a labeled specific binding member (e.g., as described herein). In some embodiments, the system for analyzing a sample is a fluorescence microscope system, including: a fluorescence microscope comprising a sample field of view; and a composition disposed in the sample field of view, wherein the composition comprises a sample; and a labeled specific binding member (e.g., as described herein).
[0269] In certain embodiments of the system, the composition further comprises a second specific binding member that is support-bound and specifically binds to the target analyte. In some cases, the support comprises magnetic particles. Therefore, in some cases, the system may also include a controllable external paramagnetic field configured to be applied to the assay region of the flow channel.
[0270] The sample may comprise cells. In some cases, the sample is a biological sample containing cells. In some cases, the sample comprises a labeled specific binding member that specifically binds to the target cell. In some cases, the target analyte specifically bound by the specific binding member is a cell surface marker of the cell. In some cases, the cell surface marker is selected from a cell receptor and a cell surface antigen.
[0271] In some cases, the system may further include a light source configured to direct light to the assay region of the flow channel or the sample field of view. The system may include a detector configured to receive a signal from the assay region of the flow channel or the sample field of view, wherein the signal is provided by the fluorescent composition. Optionally, the sample analysis system may include one or more additional detectors and / or light sources for detecting one or more additional signals.
[0272] In some aspects, the system may further include a computer-based system configured to detect the presence of a fluorescent signal. "Computer-based system" refers to hardware devices, software devices, and data storage devices that are used to analyze the information of the present invention. The minimum hardware of the computer-based system of the present invention includes a central processing unit (CPU), an input device, an output device, and a data storage device. The technician can easily recognize that any currently available computer-based system is suitable for use in the subject system. The data storage device can include any product that includes any record of the present information as described above, or a storage accessor that can access this product.
[0273] "Recording" data, programming or other information on a computer readable medium refers to the process of storing the information using any such method known in the art. Any convenient data storage structure may be selected based on the means used to access the stored information. Storage may be performed using a variety of data processor programs and formats (e.g., word processing text files, database formats, etc.).
[0274] "Processor" refers to any hardware and / or software combination that performs its required functions. For example, any processor herein may be a programmable digital microprocessor, such as available in the form of an electronic controller, a mainframe, a server, or a personal computer (desktop or portable). In the case where the processor is programmable, suitable programming may be transmitted to the processor from a remote location, or may be pre-stored in a computer program product (such as a portable or fixed computer-readable storage medium, whether based on magnetic, optical, or solid-state devices). For example, a magnetic medium or an optical disk may carry a program and may be read by a suitable reader that communicates with each processor at its corresponding site.
[0275] In addition to the sensor device and the signal processing module, for example as described above, the system of the present invention may include many additional components, such as data output devices, such as displays and / or speakers, data input devices (such as interface terminals, keyboards, etc.), fluid processing components, power supplies, etc.
[0276] In certain aspects, the system comprises a flow cytometer. Suitable flow cytometry systems may include, but are not limited to, Ormerod (ed.), Flow Cytometry: A Practical Approach, Oxford Univ. Press (1997); Jaroszeski et al. (eds.), Flow Cytometry Protocols, Methods in Molecular Biology No. 91, Humana Press (1997); Practical Flow Cytometry, 3rd edition, Wiley-Liss (1995); Virgo, et al. (2012) Ann Clin Biochem. Jan; 49 (pt 1): 17-28; Linden, et al., Semin Throm Hemost. 2004 Oct; 30 (5): 502-11; Alison, et al. J Pathol, 2010 Dec; 222 (4): 335-344; and Herbig, et al. (2007) Crit Rev Ther Drug Carrier Syst. 24(3):203-255; the disclosure of which is incorporated herein by reference. In some cases, flow cytometry systems of interest include BD Biosciences FACSCanto TM Flow cytometer, BD Biosciences FACSCanto TM II flow cytometer, BD Accuri TM Flow cytometer, BD Accuri TM C6 Plus flow cytometer, BD Biosciences FACSCelesta TM Flow cytometer, BD Biosciences FACSLyric TM Flow cytometer, BD Biosciences FACSVerse TM Flow cytometer, BD Biosciences FACSymphony TM Flow cytometer, BD Biosciences LSRFortessa TMFlow cytometer, BD Biosciences LSRFortessa TM X-20 flow cytometer, BD Biosciences FACSPresto TM Flow cytometer, BD Biosciences FACSVia TM Flow cytometer and BD Biosciences FACSCalibur TM Cell sorter, BD Biosciences FACSCount TM Cell sorter, BD Biosciences FACSLyric TM Cell sorter, BD Biosciences Via TM Cell sorter, BD Biosciences Influx TM Cell sorter, BD Biosciences Jazz TM Cell sorter, BD Biosciences Aria TM Cell sorter, BD Biosciences FACSAria TM II cell sorter, BD Biosciences FACSAria TM III cell sorter, BD Biosciences FACSAria TM Fusion Cell Sorter and BD Biosciences FACSMelody TM Cell sorter, BD Biosciences FACSymphony TM S6 cell sorter, etc.
[0277] In some embodiments, the subject system is a flow cytometry system, such as U.S. Pat. Nos. 10,663,476, 10,620,111, 10,613,017, 10,605,713, 10,585,031, 10,578,542, 10,578,469, 10,481,074, 10,302,545, 10,145,793, 10,113,967, 10,006,852, 9,952,076, 9,933,341, 9,726,527, 9,453,789, 9,200,334, 9,097,640, 9,947,834, and 9,113,967. those described in, for example, 4,084,975,595, 4,095,494, 9,092,034, 8,975,595, 8,753,573, 8,233,146, 8,140,300, 7,544,326, 7,201,875, 7,129,505, 6,821,740, 6,813,017, 6,809,804, 6,372,506, 5,700,692, 5,643,796, 5,627,040, 5,620,842, 5,602,039, 4,987,086, and 4,498,766, the disclosures of which are incorporated herein by reference in their entireties.
[0278] In some cases, the flow cytometry systems of the present invention are configured to image particles in a flow stream by fluorescence imaging using radio frequency labeled emission (FIRE), such as described in Diebold, et al. Nature Photonics Vol. 7(10); 806-810 (2013) and in U.S. Pat. Nos. 9,423,353, 9,784,661, 9,983,132, 10,006,852, 10,078,045, 10,036,699, 10,222,316, 10,288,546, 10,324,019, 10,40 8,758, 10,451,538, 10,620,111 and those described in U.S. Patent Publication Nos. 2017 / 0133857, 2017 / 0328826, 2017 / 0350803, 2018 / 0275042, 2019 / 0376895 and 2019 / 0376894, the disclosures of which are incorporated herein by reference.
[0279] Other systems can also be used to practice the subject method. In some aspects, the system can be a fluorometer or a microscope loaded with a sample of the fluorescent composition of any embodiment discussed herein. The fluorometer or microscope can include a light source configured to direct light to the assay area or sample visual field of the flow channel. The fluorometer or microscope can also include a detector configured to receive a signal from the assay area or visual field of the flow channel, wherein the signal is provided by the fluorescent composition.
[0280] Reagent test kit
[0281] Aspects of the present invention further include kits for practicing subject methods and compositions. Compositions of the present invention can be included in kits as reagents or as starting materials, or are provided for, for example, in the above-mentioned methods. Kits can include specific binding members (for example, as described above) and containers of labels. Any convenient container can be used, such as holes, boxes, bags, heat-insulated containers, etc. in tubes, bottles, or porous strips or plates. The subject kit can also include one or more components and instructions for use selected from primer specific binding members, support binding specific binding members, cells, support, biocompatibility aqueous elution buffer, controls (positive and / or negative) etc. for given target analytes as required. A given kit can include reagents suitable for detecting a single target analyte, or multiple reagents suitable for detecting two or more different target analytes, for example, wherein a given kit is configured to be used for multiple detection applications.
[0282] In certain embodiments, the kit is used to assess the presence of a target analyte (such as an intracellular target) in a sample. Thus, in some cases, the kit comprises one or more components suitable for permeabilization or lysis of cells. One or more additional components of the kit can be provided in a separate container (e.g., a separate tube, bottle, or porous strip or plate well).
[0283] In some cases, the kit further comprises a reagent for performing flow cytometry. Reagents of interest include but are not limited to buffers for reconstruction and dilution, buffers for contacting cell samples with chromophores, washing buffers, control cells, control beads, fluorescent beads for flow cytometry calibration, and combinations thereof. The kit can also include one or more cell fixatives, such as paraformaldehyde, glutaraldehyde, methanol, acetone, formalin, or any combination thereof or buffer. In addition, the kit can include cell permeabilization reagents, such as methanol, acetone or detergents (for example, triton, NP-40, saponin, tween 20, digitonin, leucoperm, or any combination thereof or buffer. Other protein transport inhibitors, cell fixation reagents, and cell permeabilization reagents familiar to those skilled in the art are within the scope of the subject kit.
[0284] The composition of the kit can be provided as a liquid composition, such as any suitable buffer. Alternatively, the composition of the kit can be provided as a dry composition (e.g., it can be lyophilized), and the kit can optionally include one or more buffers for reconstructing the dry composition. In some aspects, the kit can include aliquots of the composition, which are provided in separate containers (e.g., separate tubes, bottles, or porous strips or plate mesopores).
[0285] In addition, one or more components can be combined into a single container such as a glass or plastic vial, tube or bottle. In some cases, the test kit may further include a container (e.g., a box, bag, insulated container, bottle, tube, etc.) in which all components (and their individual containers) are present. The test kit may further include a package that is separate from or attached to the test kit container and printed with information about the test kit, components and / or instructions for use of the test kit.
[0286] Except above-mentioned component, theme test kit can further comprise the explanation for practicing theme method.These explanations can be present in theme test kit in various forms, and one or more of them can be present in test kit.One of the forms that these explanations can exist is as the packaging, package insert etc. of printed information, test kit on suitable medium or substrate (for example, one or more sheets of paper printed with information).Another means can be computer readable medium, for example, floppy disk, CD, DVD, portable flash drive etc. recorded with information.Another means that can exist is website address, and this website address can be used to access the information at the removed site by the Internet.Any convenient means can be present in test kit.
[0287] use
[0288] As described herein, purple excitable tandem dyes and specific binding members of labels comprising the dyes can be used for a variety of applications, including diagnostic and research applications in which the labeling, detection and / or analysis of a target of interest is required. Such applications include methods such as cell counting, microscopy, immunoassays (e.g., competitive or non-competitive), assessment of free analytes, assessment of receptor-bound ligands, etc. The compositions, systems and methods described herein can be used for analyzing any of a variety of samples, including but not limited to biological fluids, cell culture samples and tissue samples. In some aspects, the compositions, systems and methods described herein can be used for methods in which analytes (if present) in samples are detected using fluorescent markers, such as fluorescence-activated cell sorting or analysis, immunoassays, immunostaining, etc. In some cases, the compositions and methods are used for applications in which the presence of a target analyte in a sample is intentionally assessed.
[0289] In some cases, the methods and compositions are used in any assay format where it is intended to detect and / or analyze a target from a sample, including but not limited to flow cytometry, fluorescence microscopy, in situ hybridization, enzyme-linked immunosorbent assay (ELISA), Western blot analysis, magnetic cell separation assays, and fluorescent dye purification chromatography. In some cases, the methods and compositions are used in any application where it is intended to fluorescently label a target molecule. The subject compositions can be adapted for any convenient application using a specific binding member pair, such as biotin-streptavidin and hapten-anti-hapten antibody.
[0290] The following examples are offered by way of illustration and not limitation.
[0291] Example
[0292] I. Synthesis of Water-Soluble Purple Excitable Coumarin Donor Fluorophores C, G, and H
[0293] A. Synthesis of Compound C
[0294]
[0295] Compound 1C: Reaction A of POCl3 (40.82 mg, 266.23 umol, 24.74 uL, 0.1 eq.) in DMF (45 mL) was carried out at 0°C under N2 atmosphere for 0.5 h, and a mixture B of 3-[bis[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]phenol (3.18 g, 2.66 mmol, 1 eq.) in DMF (40 mL) was added to the stirred solution. The resulting mixture was stirred at 25°C for 16 h. The reaction mixture was acidified to pH=7 with Na2CO3, and the mixture was stirred at 55°C under N2 atmosphere for 3 h. With DCM (200mL) and H o (100mL) extraction mixture, wash the combined organic phase with brine (100mL), use anhydrous Na sO dry, concentrate to obtain crude residue.Residue is used for next step without purification.Obtain as light black oily compound 4-[bis[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]-2-hydroxy-benzaldehyde (compound 1C) (1.83g, 1.18mmol, 44.31% yield, 78.8% purity).
[0296]
[0297] Compound 2C: To a solution of 2-(1H-benzimidazol-2-yl)acetonitrile (2g, 12.72mmol, 1 equivalent) in DCM (100mL) was added DBU (2.32g, 15.27mmol, 2.30mL, 1.2 equivalents) and ethyl 4-bromobutyrate (3.72g, 19.09mmol, 2.74mL, 1.5 equivalents). The mixture was stirred at 50 ° C for 16 hours under N2. The mixture was concentrated under reduced pressure to obtain a residue. The residue was purified by flash silica gel chromatography. 4-[2-(cyanomethyl)benzimidazol-1-yl]ethyl butyrate (compound 2C) (1.33g, 4.52mmol, 35.52% yield, 92.2% purity) was obtained as a dark black oil.
[0298]
[0299] Compound 3C: Under N2 atmosphere, piperidine (27.86 mg, 327.21 umol, 32.31 uL, 2 equivalents) was added to a solution of compound 1C (0.2 g, 163.61 umol, 1 equivalent) and compound 2C (66.58 mg, 245.41 umol, 1.5 equivalents) in EtOH (4 mL). Some yellow solids were precipitated in the mixture. The suspension was stirred at 55 ° C for 16 hours. The mixture was dissolved in DCM (50 mL), washed with water (20 mL) and brine (10 mL), the organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure to obtain a residue. Under N2 atmosphere, the crude product was stirred at 100 ° C for 2 hours in 2% HCl (2 mL). The mixture was cooled at room temperature, then dissolved in DCM (100 mL), washed with water (10 mL) and brine (10 mL), the organic layer was dried with Na2SO4, filtered and concentrated under reduced pressure to obtain a residue. Ethyl 4-[2-[7-[bis[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]-2-oxo-chroman-3-yl]benzimidazol-1-yl]butanoate (Compound 3C) was obtained as a yellow oil (0.25 g, 155.75 umol, yield 95.20%, purity 92%).
[0300]
[0301] Compound C:Compound 3C (0.05 g, 33.86 umol, 1 eq) was dissolved in HCl (2.04 g, 5.60 mmol, 2 mL, 10% purity, 165.25 eq) at 100 °C under N2 atmosphere for 1 hour. The mixture was dissolved in DCM (50 mL), the organic layer was dried over Na2SO4, filtered and concentrated under reduced pressure to obtain a residue. The resulting residue was purified by preparative HPLC. Compound 4-[2-[7-[bis[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]-2-oxo-chroman-3-yl]benzimidazol-1-yl]butanoic acid (Compound C) (0.75 g, 509.95 umol, yield 56.83%, purity 98.5%) was obtained as a yellow oil
[0302] B. Synthesis of Compound G
[0303]
[0304] Compound 1G : 1,3-Difluoro-2,4-dimethoxy-benzene (3 g, 17.23 mmol, 1 eq) was diluted in DCM (114 mL) and BBr3 (1 M, 111.11 mL, 6.45 eq) was added via cannula at 20°C. The resulting clear light brown solution was stirred at 20°C for 40 hours. The reaction was slowly added to an ice-water suspension (400 mL), resulting in the formation of a precipitate, thereby quenching the reaction. The resulting suspension was stirred at room temperature until the precipitate dissolved. The organic layer was decanted and the aqueous layers of the two reactions were combined and extracted with CH2Cl2 (3×50 mL) until almost colorless. The CH2Cl2 layer was discarded and the aqueous layer was extracted with MTBE (3×300 mL). The combined ether layers were dried (MgSO4), filtered, and concentrated under reduced pressure to give a light gray semisolid. The solid was re-placed in CH2Cl2 until a precipitate (10 mL) was formed, and the solvent was then removed under reduced pressure until a free-flowing light gray powder was obtained, thereby inducing crystallization. 2,4-Difluorobenzene-1,3-diol (Compound 1G) (2.5 g, 15.40 mmol, yield 89.40%, purity 90%) was obtained as a light grey solid.
[0305]
[0306] Compound 2G:TFA (46.15 g, 404.71 mmol, 29.97 mL, 23.65 eq) was charged into a 100 mL flask and cooled to 0 ° C. HMTA (4.80 g, 34.23 mmol, 6.40 mL, 2 eq) was slowly added to cold TFA under stirring at a rate that kept the reaction temperature at about 0 ° C. Solid compound 1G (2.5 g, 17.11 mmol, 1 eq) was then added in one go. The flask was equipped with a reflux condenser and flushed with N2 at about 90 ° C. The reaction mixture was refluxed for 24 hours, during which the solution slowly turned brown. The mixture was cooled to room temperature. The reaction was quenched with 20% H2SO4 aqueous solution (14 mL) at room temperature and stirred for another 4 hours at room temperature. The mixture was poured into ice water (100 mL) and extracted with EtOAc (3×50 mL). The combined organic layers were washed with brine (1×100 mL) and then directly concentrated under reduced pressure to obtain a viscous orange semi-solid. The residue was purified by flash silica gel chromatography to give 3,5-difluoro-2,4-dihydroxy-benzaldehyde (Compound 2G) (1.26 g, 7.13 mmol, 41.69% yield, 98.57% purity) as a yellow solid.
[0307]
[0308] Compound 3G: Compound 2G (1.26 g, 7.24 mmol, 1 eq.) and diethyl malonate (4.50 g, 28.08 mmol, 4.24 mL, 3.88 eq.) were charged into a flask, and MsOH (89.5 mL) was added under vigorous stirring at 20 °C. The reaction mixture was immediately shielded from light with foil and flushed with N2. The mixture was stirred for 16 hours. The mixture was poured into ice water (50 mL) and extracted with EtOAc (3×50 mL) to treat the mixture. The combined organic layers were washed with H2O (3×50 mL) and brine (1×50 mL). The organic layer was dried (Na2SO4), filtered and concentrated under reduced pressure. The residue was redissolved in MeCN (6.5 mL) in a flask, flushed with N2, and then heated until all solids were dissolved. The solution was allowed to cool slowly to room temperature and then further cooled at 4 °C for 1 hour. Yellow crystals were formed, which were collected by vacuum filtration and washed with MTBE (3×4.5 mL). The product was a fluffy yellow powder. 6,8-Difluoro-7-hydroxy-2-oxo-chromene-3-carboxylic acid ethyl ester (Compound 3G) (1.2 g, 4.31 mmol, yield 59.54%, purity 97.02%) was obtained as a light yellow solid.
[0309]
[0310] Compound 4G: NaOH (799.39 mg, 19.99 mmol, 54 eq) was dissolved in H2O (10 mL) in a flask, MeOH (2 mL) was added to the flask, and then compound 3G (0.1 g, 370.12 umol, 1 eq) was added. The reaction mixture was immediately protected from light and stirred at 20°C for 1 hour.
[0311] The reaction solution was acidified with concentrated HCl (50 mL) to make it almost colorless and extracted with EtOAc (3×100 mL). The combined organic layers were washed with brine (1×50 mL), dried (MgSO4), filtered, and concentrated under reduced pressure and protected from light. 6,8-difluoro-7-hydroxy-2-oxo-chromene-3-carboxylic acid (Compound 4G) (70 mg, 287.45 umol, yield 77.66%, purity 99.43%) was obtained as a light yellow solid.
[0312]
[0313] Compound 5G : To a solution of 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate (20 g, 22.45 mmol, 1 eq) in DMF (240 mL) was added (1,3-dihydroisoindolin-2-yl) potassium (4.99 g, 26.93 mmol, 1.2 eq). The reaction mixture was then stirred at 100 ° C under nitrogen for 12 hours to give a colorless solution. The reaction mixture was extracted with DCM (100 mL × 3) and water (200 mL), and the organic layer was washed with water (200 mL × 3). The separated organic layer was dried over Na2SO4, filtered and evaporated to obtain a residue. Compound 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]isoindoline-1,3-dione (Compound 5G) (8 g, 8.82 mmol, yield 39.28%, purity 95.43%) was obtained as a light yellow oil.
[0314]
[0315] Compound 6G: To a mixture of solid compound 5G (8 g, 9.24 mmol, 1 equivalent) and EtOH (160 mL) was added hydrazine hydrate (1.76 g, 35.10 mmol, 1.71 mL, 3.8 equivalents) at one time. It was heated to 40 ° C for 4 hours. The reaction mixture was cooled to 20 ° C, then filtered, the filter cake was washed with DCM (100 mL × 2), the filtrate was evaporated to provide a residue, the residue was dissolved in DCM (50 mL) and filtered, the filter cake was washed with DCM (50 mL × 2), and the filtrate was evaporated to provide the desired product. The residue was used directly in the next step without further purification. Compound 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamine (Compound 6G) (6.6 g, crude product) was obtained as a pale yellow oil.
[0316]
[0317] Compound 7G : To compound 6G (5g, 6.79mmol, 1 equivalent) in DMF (20mL) and H2O (15mL) solution add propene-2-enoic acid benzyl ester (1.10g, 6.79mmol, 1 equivalent). Then the reaction mixture was stirred at 20 ℃ for 16 hours under nitrogen to obtain a colorless solution. The reaction mixture was cooled to 20 ℃, then filtered, washed with DCM (20mL × 2) filter cake, evaporation filter to obtain residue, the residue was dissolved in DCM (30mL) and filtered, washed with DCM (20mL × 2) filter cake, evaporation filtrate to obtain the desired product. The crude product was purified by reversed-phase HPLC (0.075% TFA condition) to obtain product 3g. The 3g residue was purified by preparative HPLC. Compound 3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]propionic acid benzyl ester (Compound 7G) was obtained as a colorless oil (2 g, 2.00 mmol, yield 29.50%, purity 90%).
[0318]
[0319] Compound 8G: HATU (102.07 mg, 268.45 umol, 1.3 equiv) and DIEA (106.75 mg, 825.99 umol, 143.87 uL, 4 equiv) were added to a solution of compound 4G (50 mg, 206.50 umol, 1 equiv) in DMF (2 mL). The reaction mixture was stirred at 20 ° C for 0.5 hours under nitrogen. Compound 7G (222.54 mg, 247.80 umol, 1.2 equiv) was then added to the above solution and stirred at 20 ° C for 2 hours under nitrogen to obtain a green solution. The reaction mixture was poured into water (10 mL) and extracted with DCM (20 mL×3), and the combined organic phase was washed with water (20 mL) and saturated NaCl (20 mL), then dried over anhydrous Na2SO4 and concentrated to obtain a green residue. The residue was used directly in the next step without further purification. Compound 3-[(6,8-difluoro-7-hydroxy-2-oxo-chromene-3-carbonyl)-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]propionic acid benzyl ester (Compound 8G) (200 mg, crude product) was obtained as a pale yellow oil.
[0320]
[0321] Compound G: LiOH.H2O (6.42 mg, 152.94 umol, 2 equivalents) was dissolved in MeOH (1 mL) in a flask, H2O (0.2 mL) was added to the flask, and then compound 8G (0.08 g, 76.47 umol, 1 equivalent) was added. The reaction mixture was immediately protected from light and stirred at 20°C for 1 hour. The reaction solution was acidified with concentrated HCl (5 mL) to make it almost colorless and extracted with EtOAc (3×100 mL). The combined organic layer was washed with brine (1×50 mL), dried (MgSO4), filtered, and concentrated under reduced pressure, and protected from light. The residue was purified by preparative HPLC (column: Boston Green ODS150*30mm*5um; mobile phase: [water (0.075% TFA)-ACN]; B%: 15%-45%, 9 minutes). Compound 3-[(6,8-difluoro-7-hydroxy-2-oxo-chromene-3-carbonyl)-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]propanoic acid (Compound G) was obtained as a colorless oil (40 mg, 38.72 umol, yield 50.63%, purity 99.9%).
[0322] C. Synthesis of Compound H
[0323]
[0324] Compound 1H : 3-benzyloxyaniline (20g, 100.38mmol, 1 equivalent), 2-bromoethanol (50.17g, 401.51mmol, 28.51mL, 4 equivalents), CaCO3 (20.09g, 200.75mmol, 2 equivalents), KI (1.67g, 10.04mmol, 0.1 equivalent) in H2O (200mL), the mixture was stirred at 100°C for 16 hours. The mixture was extracted with ethyl acetate (3×200mL), the combined organic layer was washed with brine (100mL), dried with Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, petroleum ether: ethyl acetate = 1:1). Compound 2-[3-benzyloxy-N-(2-hydroxyethyl)anilino]ethanol (30g, 89.79mmol, yield 89.45%, purity 86%) was obtained as a yellow oil.
[0325]
[0326] Compound 2H: Under N2 atmosphere, NaH (5.57 g, 139.20 mmol, 60% purity, 10 eq.) was added to a solution of compound 1H (4 g, 13.92 mmol, 1 eq.) in THF (320 mL). The mixture was stirred at 70°C for 1 hour. The mixture was then cooled to 25°C and a solution of 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate (22.41 g, 33.41 mmol, 2.4 eq.) was added dropwise. The mixture was stirred at 70°C for another 16 hours. The mixture was quenched with water (200 mL), extracted with CH2Cl2 (600 mL), and the combined organic layers were washed with brine (200 mL), dried over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, dichloromethane:methanol=10:1). Compound 2H, 3-benzyloxy-N,N-bis[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]aniline (22 g, 13.87 mmol, 99.66% yield, 81% purity) was obtained as a yellow oil, which was checked by LCMS and HPLC.
[0327]
[0328] Compound 3H Compound 2H (22 g, 17.13 mmol, 1 equivalent) was added to TFA (200 mL) to form a solution, and the mixture was stirred at 90 ° C for 16 hours. The reaction mixture was acidified to pH = 7 with NaHCO, filtered, and the filter cake was washed with H2O (200 mL) and DCM (400 mL), then concentrated under reduced pressure to give a residue, which was purified by column chromatography (SiO2, dichloromethane: methanol = 10: 1). Compound 3-[bis[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]phenol (Compound 3H) (13 g, 8.49 mmol, yield 49.57%, purity 78%) was obtained as a dark brown oil, which was checked by LCMS and HPLC.
[0329]
[0330] Compound 4H:POCl3(1.67g, 10.88mmol, 1.01mL, 1 equivalent) in DMF(130mL) was stirred for 0.5 hours at 0°C under N2 atmosphere.Compound 3H(13g, 10.88mmol, 1 equivalent) in DMF(96mL) was added to the stirred solution.The resulting mixture was stirred for 16 hours at 25°C.The reaction mixture was acidified to pH=7 with Na2CO3, and the mixture was stirred for 3 hours at 55°C under N2 atmosphere.The mixture was extracted with DCM(500mL) and H2O(300mL), the combined organic phase was washed with brine (300mL), dried over anhydrous Na2SO4, and concentrated to give a crude residue. Compound 4-[bis[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]-2-hydroxy-benzaldehyde (Compound 4H) (11.5 g, crude product) was obtained as a dark brown oil and examined by LCMS, HPLC and HNMR.
[0331]
[0332] Compound 5H:To the solution of compound 4H (2g, 1.64mmol, 1 equivalent) and diethyl malonate (786.13mg, 4.91mmol, 741.63uL, 3 equivalents) in EtOH (10mL), piperidine (278.62mg, 3.27mmol, 323.15uL, 2 equivalents) and AcOH (314.99mg, 5.25mmol, 299.99uL, 3.21 equivalents) are added. The mixture is stirred at 55 ° C for 16 hours. The mixture is quenched with water (100mL), extracted with CH2Cl2 (150mL), the combined organic layer is washed with brine (50mL), dried with Na2SO4, filtered and concentrated under reduced pressure. The residue is purified by column chromatography (SiO2, dichloromethane: methanol = 10: 1). The residue was purified by preparative HPLC (column: Welch Xtimate C18 150*30mm*5um; mobile phase: [water (FA)-ACN]; B%: 20%-50%, 7.7 minutes). 7-[bis[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]-2-oxo-chromene-3-carboxylic acid ethyl ester (Compound 5H) (350 mg, 260.14 umol, yield 26.38%, purity 98%) was obtained as a yellow oil, which was checked by LCMS and HPLC.
[0333]
[0334] Compound H Compound 5H (300 mg, 227.53 umol, 1 eq.) was stirred in 1M HCl (1M, 227.53 uL, 1 eq.) at 100°C for 1 hour. The mixture was dissolved in DCM (50 mL), the organic layer was dried over Na2SO4, filtered, and concentrated under reduced pressure to give a residue, which was purified by reverse phase column (column: 12 g C18 reverse phase column; mobile phase: [water-ACN]; B%: 0%-60%, 30 minutes). Compound 7-[bis[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]amino]-2-oxo-chromene-3-carboxylic acid (Compound H) (73.3 mg, 55.10 umol, yield 24.22%, purity 97%) was obtained as a brown oil and examined by LCMS, HPLC and 1H NMR.
[0335] II. Characterization of Compounds C, G, and H
[0336] A. UV-Vis Spectroscopy
[0337] UV-2600 spectrophotometer (dual beam, single monochromator Shimadzu Scientific Instruments) was set to collect data in 1 nm increments from 900 nm to 250 nm with a slit width of 1.0 nm. A stock solution of donor C dissolved in 1x phosphate buffered saline (PBS) was prepared and 2 mL was transferred to the sample cuvette [1-cm polymethyl methacrylate cuvette]. 2 mL of 1x PBS was then transferred to the second cuvette. The cuvette containing 1x PBS was placed in the blank cuvette position within the UV-2600, while the dye sample cuvette was placed in the sample cuvette position. The instrument absorbance was automatically zeroed at 900 nm, and UV-visible spectra were collected from 900 nm to 250 nm. The same protocol was performed for donors G and H.
[0338] B. Fluorescence spectroscopy
[0339] A small amount of donor C stock solution in 1x PBS was diluted to 25 mA.U. in a total volume of 2 mL of 1x PBS. This solution was transferred to a sample cuvette [1-cm polymethyl methacrylate cuvette] and placed in the sample chamber of the fluorometer. The excitation wavelength was set to 375 nm and the emission scan range was set to 400 nm to 900 nm. For signal detection, both the fluorescence signal (S1) and the instrument noise (R1) were recorded. The correction file applied to the raw output signal converts the S1 and R1 signals into corrected fluorescence (S1c) and corrected noise (R1c). The corrected fluorescence S1c was then normalized according to the corrected noise to obtain the final reported fluorescence emission of the sample. The same protocol was performed for donors G and H. The results are shown in Figure 1 shown.
[0340] III. Synthesis of Tandem Dyes with Violet Excitable Donor Fluorophores
[0341] A summary of various methods that can be used to synthesize tandem dyes with violet excitable donor fluorophores can be found in Steward et al., "Solid Phase Peptide Synthesis", WH Freeman Co., San Francisco, 1969, Bodanszky et al., "Peptide Synthesis", John Wiley & Sons, 2nd edition, 1976, and Meienhofer, "Hormonal Proteins and Peptides", Vol. 2, p. 46, Academic Press (New York), 1983, and in Kent, Ann. Rev. Biochem., 57, 957, 1988 for solid phase peptide synthesis, and in Schroder et al., "The Peptides", Vol. 1, Academic Press (New York), 1965 for solution synthesis. Any convenient protecting group strategy can be used, such as, but not limited to, Fmoc solid phase peptide synthesis and Boc solid phase peptide synthesis strategies. In Boc solid phase peptide synthesis, Boc-amino protecting group is used at amino terminal, and benzyl or benzyls or other convenient protecting groups can be used to protect side chain functional groups. In Fmoc solid phase peptide synthesis, Fmoc-amino protecting group is used at amino terminal, and tert-butyl or benzyls or other convenient protecting groups can be used to protect side chain functional groups. The convenient protecting groups that can be used for such synthetic methods are described in the above-mentioned references and by McOmic "Protective Groups in Organic Chemistry", Plenum Press, New York, 1973 and Greene and Wuts, "Protective Groups in Organic Synthesis", John Wiley & Sons, the 4th edition, 2006. Tandem dyes with a violet excitable donor fluorophore and different acceptor fluorophores were prepared, namely, Tandem 570 (with an acceptor providing 570 nm emission), Tandem 600 (with an acceptor providing 600 nm emission), Tandem 650 (with an acceptor providing 650 nm emission), Tandem 712 (with an acceptor providing 712 nm emission), Tandem 750 (with an acceptor providing 750 nm emission), Tandem 780 (with an acceptor providing 780 nm emission) and Tandem 850 (with an acceptor providing 850 nm emission).
[0342] IV. Characterization of sample tandem dyes
[0343] A. UV-Vis Spectroscopy
[0344] UV-2600 spectrophotometer (double beam, single monochromator Shimadzu Scientific Instruments) is set to collect data from 900nm to 250nm with a slit width of 1.0nm in 1nm increments. Prepared a stock solution of the tandem dyes prepared in III above (i.e., tandem 570, tandem 600, tandem 650, tandem 712, tandem 750, tandem 780 or tandem 850) dissolved in 1x phosphate buffered saline (PBS), and 2mL was transferred to a sample cuvette [1-cm polymethyl methacrylate cuvette]. Then 2mL 1x PBS was transferred to a second cuvette. The cuvette containing 1x PBS was placed in the blank cuvette position in the UV-2600, and the tandem dye sample sample cuvette was placed in the sample cuvette position. The instrument absorbance was automatically zeroed at 900nm, and the UV-visible spectrum from 900nm to 250nm was collected.
[0345] B. Fluorescence spectroscopy
[0346] A stock solution of a small amount of the tandem dye (i.e., tandem 570, tandem 600, tandem 650, tandem 712, tandem 750, tandem 780, or tandem 850) prepared in III above was diluted to 25 mA.U. in a total volume of 2 mL 1x PBS. The solution was transferred to a sample cuvette [1-cm polymethyl methacrylate cuvette] and placed in the sample chamber of the fluorometer. The excitation wavelength was set to 405 nm and the emission scan range was set to 415 nm to 900 nm. For signal detection, both the fluorescence signal (S1) and the instrument noise (R1) were recorded. The correction file applied to the raw output signal converts the S1 and R1 signals into corrected fluorescence (S1c) and corrected noise (R1c). The corrected fluorescence S1c is then normalized according to the corrected noise to obtain the final reported fluorescence emission of the sample. The results are provided in Figure 2 middle.
[0347] Notwithstanding the appended claims, the present disclosure is also defined by the following clauses:
[0348] 1. A tandem dye comprising:
[0349] Non-conjugated polymer backbone;
[0350] one or more violet excitable donor fluorophores attached to the non-conjugated polymer backbone; and
[0351] one or more acceptor fluorophores attached to the non-conjugated polymer backbone,
[0352] The donor fluorophore and the acceptor fluorophore are in an energy transfer relationship.
[0353] 2. The tandem dye according to item 1, wherein the one or more violet excitable donor fluorophores are selected to have an absorption maximum ranging from 375 to 425 nm.
[0354] 3. The tandem dye according to item 1 or 2, wherein the one or more violet excitable donor fluorophores are selected from the group consisting of a coumarin fluorophore, a pyrene fluorophore and a triphenyl fluorophore.
[0355] 4. The tandem dye according to item 3, wherein the one or more violet excitable donor fluorophores are coumarin fluorophores.
[0356] 5. A tandem dye according to any one of the preceding items, wherein the one or more violet excitable donor fluorophores are bonded to a water soluble group.
[0357] 6. The tandem dye according to item 5, wherein the water-soluble group comprises a non-ionic water-soluble group.
[0358] 7. The tandem dye according to item 6, wherein the non-ionic water-soluble group comprises a polyalkylene glycol.
[0359] 8. The tandem dye according to item 7, wherein the polyalkylene glycol comprises polyethylene glycol.
[0360] 9. A tandem dye according to any of the preceding items, wherein the emission maximum of the one or more acceptor fluorophores ranges from 500 to 875 nm.
[0361] 10. A tandem dye according to any of the preceding items, wherein the one or more acceptor fluorophores are selected from coumarin dyes, cyanine dyes, rhodamine dyes, xanthene dyes, polymethines, dipyrromethene boron difluoride, naphthylimide, thiazine dyes and acridine dyes.
[0362] 11. A tandem dye according to any of the preceding items, wherein the number of donor fluorophores exceeds the number of acceptor fluorophores.
[0363] 12. The tandem dye according to item 11, wherein the number of donor fluorophores ranges from 2 to 20.
[0364] 13. A tandem dye according to any of the preceding items, wherein the dye comprises a single acceptor fluorophore.
[0365] 14. A tandem dye according to any of the preceding items, wherein the tandem dye is linked to a biomolecule.
[0366] 15. The tandem dye according to item 14, wherein the biomolecule is selected from the group consisting of carbohydrates, lipids, nucleic acids and proteins.
[0367] 16. The tandem dye according to item 15, wherein the biomolecule is a specific binding member.
[0368] 17. The tandem dye according to item 16, wherein the specific binding member is an antibody or a binding fragment or derivative thereof.
[0369] 18. The tandem dye according to any one of items 1 to 13, wherein the tandem dye is linked to a chemoselective group.
[0370] 19. A tandem dye according to any of the preceding items, wherein the non-conjugated polymer backbone comprises a peptide.
[0371] 20. The tandem dye according to item 19, wherein the peptide comprises 5 to 100 amino acid residues.
[0372] 21. A method of assessing the presence of a target analyte in a sample, the method comprising:
[0373] (a) contacting the sample with a labeled specific binding member that specifically binds to the target analyte to produce a labeled sample, wherein the labeled specific binding member comprises a specific binding member conjugated to a tandem dye, the tandem dye comprising:
[0374] Non-conjugated polymer backbone;
[0375] one or more violet excitable donor fluorophores attached to the non-conjugated polymer backbone; and
[0376] one or more acceptor fluorophores attached to the non-conjugated polymer backbone,
[0377] wherein the donor fluorophore and the acceptor fluorophore are in an energy transfer relationship; and
[0378] (b) assaying the labeled composition for the presence of a labeled specific binding member-target analyte binding complex to assess the presence or absence of the target analyte in the sample.
[0379] 22. The method according to item 21, wherein the one or more violet excitable donor fluorophores are selected to have an absorption maximum ranging from 375 to 425 nm.
[0380] 23. The method according to item 21 or 22, wherein the one or more violet excitable donor fluorophores are selected from the group consisting of a coumarin fluorophore, a pyrene fluorophore and a triphenyl fluorophore.
[0381] 24. The method according to item 23, wherein the one or more violet excitable donor fluorophores are coumarin fluorophores.
[0382] 25. The method according to any one of items 21 to 24, wherein the one or more violet excitable donor fluorophores are bonded to a water soluble group.
[0383] 26. The method according to item 25, wherein the water-soluble groups comprise non-ionic water-soluble groups.
[0384] 27. The method according to item 26, wherein the non-ionic water-soluble group comprises a polyalkylene glycol.
[0385] 28. The method according to item 27, wherein the polyalkylene glycol comprises polyethylene glycol.
[0386] 29. The method according to any one of items 21 to 28, wherein the one or more acceptor fluorophores have an emission maximum in the range of 500 to 875 nm.
[0387] 30. The method according to any one of items 21 to 29, wherein the one or more acceptor fluorophores are selected from coumarin dyes, cyanine dyes, rhodamine dyes, xanthene dyes, polymethines, dipyrromethene boron difluoride, naphthylimide, thiazine dyes and acridine dyes.
[0388] 31. The method according to any one of items 21 to 30, wherein the number of donor fluorophores exceeds the number of acceptor fluorophores.
[0389] 32. The method according to item 31, wherein the number of donor fluorophores ranges from 2 to 20.
[0390] 33. Method according to any one of items 21 to 32, wherein the tandem dye comprises a single acceptor fluorophore.
[0391] 34. The method according to item 33, wherein the specific binding member is an antibody or a binding fragment or derivative thereof.
[0392] 35. Method according to any one of items 21 to 34, wherein said polymer backbone comprises a peptide.
[0393] 36. The method according to item 35, wherein the peptide comprises 2 to 100 amino acid residues.
[0394] 37. The method according to any one of items 21 to 36, further comprising contacting said sample with a second specific binding member which is support-bound and specifically binds to said target analyte.
[0395] 38. The method according to item 37, wherein the support comprises magnetic particles.
[0396] 39. The method according to any one of items 21 to 38, wherein the target analyte is associated with a cell.
[0397] 40. The method according to item 39, wherein said target analyte is a cell surface marker of said cell.
[0398] 41. The method according to item 40, wherein said cell surface marker is selected from a cell receptor and a cell surface antigen.
[0399] 42. The method according to any one of items 21 to 39, wherein the target analyte is an intracellular target.
[0400] 43. The method according to item 42, wherein the method further comprises permeabilizing or lysing the cells.
[0401] 44. The method according to any one of items 21 to 43, wherein said determining comprises analyzing said labeled sample by flow cytometry.
[0402] 45. A method for synthesizing a fluorescently labeled tandem dye, the method comprising:
[0403] generating a precursor non-conjugated polymer backbone comprising a first type of residue, a second type of residue, and a third type of residue having first, second, and third orthogonal reactive side chains, respectively; and
[0404] conjugating a violet excitable donor fluorophore to any first reactive side chain of the precursor non-conjugated polymer backbone, conjugating an acceptor fluorophore to any second reactive side chain of the precursor non-conjugated polymer backbone, and conjugating a biomolecule to any third reactive side chain of the precursor non-conjugated polymer backbone;
[0405] To produce the fluorescently labeled polymer tandem dye.
[0406] 46. The method according to item 45, wherein the one or more violet excitable donor fluorophores are selected to have an absorption maximum ranging from 375 to 425 nm.
[0407] 47. The method according to item 45 or 46, wherein the one or more violet excitable donor fluorophores are selected from the group consisting of a coumarin fluorophore, a pyrene fluorophore and a triphenyl fluorophore.
[0408] 48. The method according to item 47, wherein the one or more violet excitable donor fluorophores are coumarin fluorophores.
[0409] 49. The method according to any one of items 45 to 48, wherein the one or more violet excitable donor fluorophores are bonded to a water soluble group.
[0410] 50. The method according to item 49, wherein the water-soluble groups comprise non-ionic water-soluble groups.
[0411] 51. The method according to item 40, wherein the non-ionic water-soluble group comprises a polyalkylene glycol.
[0412] 52. The method according to item 51, wherein the polyalkylene glycol comprises polyethylene glycol.
[0413] 53. Method according to any of items 45 to 52, wherein the one or more acceptor fluorophores have an emission maximum in the range of 500 to 875 nm.
[0414] 54. The method according to any one of items 45 to 53, wherein the one or more acceptor fluorophores are selected from coumarin dyes, cyanine dyes, rhodamine dyes, xanthene dyes, polymethines, dipyrromethene boron difluoride, naphthylimide, thiazine dyes and acridine dyes.
[0415] 55. The method according to any one of items 45 to 54, wherein the number of donor fluorophores exceeds the number of acceptor fluorophores.
[0416] 56. The method according to item 55, wherein the number of donor fluorophores ranges from 2 to 20.
[0417] 57. Method according to any one of items 45 to 56, wherein the tandem dye comprises a single acceptor fluorophore.
[0418] 58. Method according to any one of items 45 to 57, wherein said biomolecule is selected from the group consisting of carbohydrates, lipids, nucleic acids and proteins.
[0419] 59. The method according to item 58, wherein the biomolecule is a specific binding member.
[0420] 60. The method according to item 59, wherein the specific binding member is an antibody or a binding fragment or derivative thereof.
[0421] 61. The method according to any one of items 45 to 60, wherein the non-conjugated polymer backbone comprises a peptide.
[0422] 62. The method according to item 61, wherein the peptide comprises 5 to 100 amino acid residues.
[0423] 63. A kit comprising:
[0424] A tandem dye, the tandem dye comprising:
[0425] Non-conjugated polymer backbone;
[0426] one or more violet excitable donor fluorophores attached to the non-conjugated polymer backbone; and
[0427] one or more acceptor fluorophores attached to the non-conjugated polymer backbone,
[0428] The donor fluorophore and the acceptor fluorophore are in an energy transfer relationship.
[0429] 64. The kit according to item 63, wherein the one or more violet excitable donor fluorophores are selected to have an absorption maximum ranging from 375 to 425 nm.
[0430] 65. The kit according to item 63 or 64, wherein the one or more violet excitable donor fluorophores are selected from the group consisting of a coumarin fluorophore, a pyrene fluorophore and a triphenyl fluorophore.
[0431] 66. The kit according to item 65, wherein the one or more violet excitable donor fluorophores are coumarin fluorophores.
[0432] 67. The kit according to any one of items 63 to 66, wherein the one or more violet excitable donor fluorophores are bonded to a water soluble group.
[0433] 68. The kit according to item 67, wherein the water-soluble group comprises a non-ionic water-soluble group.
[0434] 69. The kit according to item 68, wherein the non-ionic water-soluble group comprises a polyalkylene glycol.
[0435] 70. The kit according to item 69, wherein the polyalkylene glycol comprises polyethylene glycol.
[0436] 71. The kit according to any of items 63 to 70, wherein the one or more acceptor fluorophores have an emission maximum in the range of 500 to 875 nm.
[0437] 72. The kit according to any one of items 63 to 71, wherein the one or more acceptor fluorophores are selected from coumarin dyes, cyanine dyes, rhodamine dyes, xanthene dyes, polymethines, dipyrromethene boron difluoride, naphthylimide, thiazine dyes and acridine dyes.
[0438] 73. Kit according to any of items 63 to 72, wherein the number of donor fluorophores exceeds the number of acceptor fluorophores.
[0439] 74. The kit according to item 73, wherein the number of donor fluorophores ranges from 2 to 20.
[0440] 75. Kit according to any one of items 63 to 74, wherein the tandem dye comprises a single acceptor fluorophore.
[0441] 76. The kit according to any of items 63 to 75, wherein the tandem dye is linked to a biomolecule.
[0442] 77. The kit according to item 76, wherein the biomolecule is selected from the group consisting of carbohydrates, lipids, nucleic acids and proteins.
[0443] 78. The kit according to item 76, wherein said biomolecule is a specific binding member.
[0444] 79. The kit according to item 78, wherein the specific binding member is an antibody or a binding fragment or derivative thereof.
[0445] 80. The kit according to any of items 63 to 75, wherein the tandem dye is linked to a chemoselective group.
[0446] 81. Kit according to any of items 63 to 80, wherein said non-conjugated polymer backbone comprises a peptide.
[0447] 82. Kit according to item 81, wherein said peptide comprises 5 to 100 amino acid residues.
[0448] In at least some of the previously described embodiments, one or more elements used in one embodiment may be used interchangeably in another embodiment, unless such replacement is technically infeasible. It will be appreciated by those skilled in the art that various other omissions, additions and modifications may be made to the above methods and structures without departing from the scope of the claimed subject matter. All such modifications and changes are intended to fall within the scope of the subject matter defined by the appended claims.
[0449] Those skilled in the art will understand that, in general, the terms used herein, and particularly the terms used in the appended claims (e.g., the bodies of the appended claims), are generally intended to be "open" terms (e.g., the term "including" should be interpreted as "including but not limited to," the term "having" should be interpreted as "having at least," the term "comprising" should be interpreted as "including but not limited to," etc.). Those skilled in the art will also understand that if a specific number of introduced claim recitations is intended, such an intent will be explicitly recited in the claim, and in the absence of such a recitation, no such intent is present. For example, to aid understanding, the following appended claims may contain the use of the introductory phrases "at least one" and "one or more" to introduce claim recitations. However, the use of such phrases should not be construed as implying that the introduction of a claim recitation by the indefinite article "a" or "an" limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases "one or more" or "at least one" and an indefinite article such as "a" or "an" (e.g., "a" and / or "an" should be construed to mean "at least one" or "one or more"); the same applies to the use of definite articles to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, one skilled in the art will recognize that such recitation should be construed to mean at least the recited number (e.g., the mere recitation "two recitations" without other modifiers means at least two recitations, or two or more recitations). Furthermore, in those cases where a convention similar to "at least one of A, B, and C, etc." is used, generally speaking, such construction is intended that a person skilled in the art will understand the meaning of the convention (e.g., "a system having at least one of A, B, and C" would include, but is not limited to, systems: A alone, B alone, C alone, A and B together, A and C together, B and C together, and / or A, B, and C together, etc.). Furthermore, in those cases where a convention similar to "at least one of A, B, or C, etc." is used, generally speaking, such construction is intended that a person skilled in the art will understand the meaning of the convention (e.g., "a system having at least one of A, B, or C" would include, but is not limited to, systems: A alone, B alone, C alone, A and B together, A and C together, B and C together, and / or A, B, and C together, etc.). Those skilled in the art will also understand that virtually any transitional word and / or phrase presenting two or more alternative terms, whether in the specification, claims, or drawings, should be understood to contemplate the possibility of including one, either, or both of the terms. For example, the phrase "A or B" will be understood to include the possibilities of "A" or "B" or "A and B."
[0450] In addition, where features or aspects of the disclosure are described in terms of Markush groups, those skilled in the art will recognize that the disclosure is also thereby described in terms of any individual member or subgroup of members of the Markush group.
[0451] As will be understood by those skilled in the art, for any and all purposes, for example, in terms of providing a written description, all ranges disclosed herein also encompass any and all possible sub-ranges and combinations of sub-ranges thereof. Any listed range can be easily considered to be fully described and enables the same range to be decomposed into at least equal halves, one-third, one-quarter, one-fifth, one-tenth, etc. As a non-limiting example, each range discussed herein can be easily decomposed into a lower third, a middle third, and an upper third, etc. As will also be understood by those skilled in the art, all such as "until", "at least", "greater than", "less than" and similar languages include the numbers listed and refer to the ranges that can be subsequently decomposed into sub-ranges as described above. Finally, as will be understood by those skilled in the art, the range includes each individual member. Therefore, for example, a group with 1-3 articles refers to a group with 1, 2 or 3 articles. Similarly, a group with 1-5 articles refers to a group with 1, 2, 3, 4 or 5 articles, and so on.
[0452] Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be apparent to one skilled in the art in light of the teachings of this invention that certain changes and modifications may be made without departing from the spirit or scope of the appended claims.
[0453] Therefore, the foregoing only illustrates the principles of the present invention.It should be understood that those skilled in the art will be able to think of various arrangements, although not explicitly described or shown herein, these arrangements embody the principles of the present invention and are included in its spirit and scope.In addition, all examples and conditional language recorded herein are mainly intended to help readers understand the principles of the present invention and the concepts contributed by the inventors to promote this area, and should be interpreted as not being limited to such specific examples and conditions of recording.In addition, all statements of the principles, aspects and embodiments of the present invention and their specific examples recorded herein are intended to cover their structural and functional equivalents.In addition, such equivalents are intended to include currently known equivalents and equivalents developed in the future, that is, no matter how the structure, any element of the developed performance of the same function.In addition, any content disclosed herein is not intended to be dedicated to the public, regardless of whether such disclosures are clearly recorded in the claims.
[0454] Therefore, the scope of the present invention is not intended to be limited to the exemplary embodiments shown and described herein. Instead, the scope and spirit of the present invention are embodied by the appended claims. In the claims, 35 U.S.C. § 112 (f) or 35 U.S.C. § 112 (6) is expressly defined as being cited for such a limitation in a claim only when the exact phrase "means for" or the exact phrase "step for" is recited at the beginning of a certain limitation in a claim; if such exact phrase is not used in the limitation in a claim, 35 U.S.C. § 112 (f) or 35 U.S.C. § 112 (6) is not cited.
Claims
1. A tandem dye comprising: Non-conjugated polymer backbone; one or more violet excitable donor fluorophores attached to the non-conjugated polymer backbone; and one or more acceptor fluorophores attached to the non-conjugated polymer backbone, The donor fluorophore and the acceptor fluorophore are in an energy transfer relationship.
2. The tandem dye of claim 1, wherein the one or more violet excitable donor fluorophores are selected to have an absorption maximum ranging from 375 to 425 nm.
3. The tandem dye according to claim 1 or 2, wherein the one or more violet excitable donor fluorophores are selected from the group consisting of a coumarin fluorophore, a pyrene fluorophore and a triphenyl fluorophore. The tandem dye of claim 3 , wherein the one or more violet excitable donor fluorophores are coumarin fluorophores.
5. A tandem dye according to any one of the preceding claims, wherein the one or more violet excitable donor fluorophores are bonded to a water soluble group. The tandem dye according to claim 5 , wherein the water-soluble group comprises a non-ionic water-soluble group.
7. The tandem dye of claim 6, wherein the non-ionic water-soluble group comprises a polyalkylene glycol.
8. The tandem dye of claim 7, wherein the polyalkylene glycol comprises polyethylene glycol.
9. A tandem dye according to any one of the preceding claims, wherein the one or more acceptor fluorophores have an emission maximum in the range of 500 to 875 nm.
10. A tandem dye according to any one of the preceding claims, wherein the one or more acceptor fluorophores are selected from coumarin dyes, cyanine dyes, rhodamine dyes, xanthene dyes, polymethines, dipyrromethene boron difluoride, naphthylimide, thiazine dyes and acridine dyes.
11. A tandem dye according to any one of the preceding claims, wherein the number of donor fluorophores exceeds the number of acceptor fluorophores.
12. The tandem dye according to any one of the preceding claims, wherein the tandem dye is linked to a biomolecule.
13. The tandem dye according to claim 12, wherein the biomolecule is selected from the group consisting of carbohydrates, lipids, nucleic acids and proteins.
14. A method of assessing the presence of a target analyte in a sample, the method comprising: (a) contacting the sample with a labeled specific binding member that specifically binds to the target analyte to produce a labeled sample, wherein the labeled specific binding member comprises a specific binding member conjugated to a tandem dye, the tandem dye comprising: Non-conjugated polymer backbone; one or more violet excitable donor fluorophores attached to the non-conjugated polymer backbone; and one or more acceptor fluorophores attached to the non-conjugated polymer backbone, wherein the donor fluorophore and the acceptor fluorophore are in an energy transfer relationship; as well as (b) assaying the labeled composition for the presence of a labeled specific binding member-target analyte binding complex to assess the presence or absence of the target analyte in the sample.
15. A method for synthesizing a fluorescently labeled tandem dye, the method comprising: generating a precursor non-conjugated polymer backbone comprising a first type of residue, a second type of residue, and a third type of residue having first, second, and third orthogonal reactive side chains, respectively; and conjugating a violet excitable donor fluorophore to any first reactive side chain of the precursor non-conjugated polymer backbone, conjugating an acceptor fluorophore to any second reactive side chain of the precursor non-conjugated polymer backbone, and conjugating a biomolecule to any third reactive side chain of the precursor non-conjugated polymer backbone; To produce the fluorescently labeled polymer tandem dye.
Citation Information
Patent Citations
Ultraviolet absorbing polymeric dyes and methods for using the same
CN107428918A
Polymer dye modification and applications
CN111320744A
Water-soluble polymeric dyes having pendant chromophores
CN112384573A
Polymeric tandem dyes with linker groups
CN113383043A
